SNY · Sanofi

preparados farmacéuticos · CIK 0001121404

Sanofi (SNY) cotiza en el NASDAQ y se dedica a preparados farmacéuticos. Aquí están 83 documentos que ha presentado ante la SEC, desde 3 sep 2025.

Genera caja: +12.631,2 M$
Sobre el capital: 0,8%
Próxima lectura: oct 2026
Último: 1 oct 2026

En esta ficha (en gris, lo que todavía no tenemos): Caja · Ensayos · Acciones · Cortas · Directivos · Accionistas · Documentos

Todavía no se publica la dilución de esta empresa. Esas cifras se recalculan por lotes los domingos, así que o no ha entrado todavía en el lote, o el dato que hay no da para afirmarlas — y una cifra a medias no se publica. Lo que ves abajo son sus documentos tal y como los presentó ante la SEC.

Caja

Lo que la empresa declara tener en caja en cada cierre, según su propio balance. A trazo discontinuo, sumando las inversiones a corto plazo, que es lo que divide los trimestres de arriba.

De 8.912,7 M$ (31 dic 2014) a 8.997,0 M$ (31 dic 2025) en caja. El eje empieza en cero.

Ensayos clínicos

1.720 ensayos registrados en clinicaltrials.gov: 130 en marcha (reclutando, o con los pacientes que ya entraron en seguimiento) y 1.590 cerrados. Cada uno tiene su ficha aquí, en castellano. Qué significa cada estado.

Estado	Fase	Ensayo	Lectura de resultados
En marcha, sin reclutar	Fase 2	Avalglucosidase alfa · Mini-COMETA Study to Assess Safety and Efficacy of Avalglucosidase Alfa Administered Every Other Week in Pediatric Patients With Infantile-onset Pompe Disease Previously Treated With Alglucosidase Alfa	sep 2019 (real)
En marcha, sin reclutar	Fase 2	Yellow fever vaccineStudy on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia	may 2022 (real)
En marcha, sin reclutar	Fase 2	Yellow fever vaccine · VYF02Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA	jun 2022 (real)
En marcha, sin reclutar	Fase 2	SAR441344 IVEsclerosis multiple	sep 2022 (real)
En marcha, sin reclutar	Fase 3	Meningococcal PolysaccharideStudy on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5- and/or 10-year Booster Doses in Children and Adolescents Vaccinated 5 or 10 Years Earlier as Toddlers	mar 2023 (real)
En marcha, sin reclutar	Fase 3	Isatuximab IV · IRAKLIASC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM	nov 2024 (real)
En marcha, sin reclutar	Fase 3	Rilzabrutinib · LUNA 3Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)	ene 2025 (real)
En marcha, sin reclutar	Fase 1	VXB-241 60 mcgVoluntarios sanos	feb 2025 (real)
En marcha, sin reclutar	Fase 3	Venglustat · LEAP2MONOStudy to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3	oct 2025 (real)
En marcha, sin reclutar	Fase 4	DupilumabA Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial)	nov 2025 (real)
En marcha, sin reclutar	Fase 2	Isatuximab · IZALCOMieloma multiple en recaida o refractario	dic 2025 (real)
En marcha, sin reclutar	Fase 2	SAR443122 · RESOLUTEDose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis	feb 2026 (real)
En marcha, sin reclutar	Fase 3	avalglucosidase alfa · Baby-COMETClinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alfa	mar 2026 (real)
En marcha, sin reclutar	Fase 1	trivalent · VXB251-001Study of an RSV-hMPV-PIV3 Trivalent Vaccine Candidate VXB-251 in Older Adults	abr 2026 (real)
En marcha, sin reclutar	Fase 3	MenACYW conjugate vaccineImmunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China	may 2026 (real)
En marcha, sin reclutar	Fase 2	DupilumabA Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))	may 2026 (real)
En marcha, sin reclutar	Fase 3	Venglustat · CARATA Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease	may 2026 (real)
En marcha, sin reclutar	Fase 3	Riliprubart · MOBILIZEA Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work	jun 2026 (real)
En marcha, sin reclutar	Fase 3	Amlitelimab · ESTUARYA Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis	jun 2026 (real)
En marcha, sin reclutar	Fase 4	NirsevimabStudy of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in India	jun 2026 (prevista, ya pasada: sin actualizar en el registro)
En marcha, sin reclutar	Fase 2	SAR441566 · SPECIFI-CDEnfermedad de Crohn	jul 2026 (real)
En marcha, sin reclutar	no aplica	Dupilumab · OPALEStudy in Adults With Severe Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab in France	jul 2026 (prevista, ya pasada: sin actualizar en el registro)
En marcha, sin reclutar	Fase 2	AmlitelimabA Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease	ago 2026 (real)
En marcha, sin reclutar	Fase 2	SAR441566 · SPECIFI-UCA Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis	ago 2026 (real)
Reclutando pacientes	no aplica	Nirsevimab Respiratory…RSV Immunisation Status in Queensland (Australia)	ago 2026 (prevista, ya pasada: sin actualizar en el registro)
Reclutando pacientes	Fase 2	Rilzabrutinib dose 1A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease	ago 2026 (prevista, ya pasada: sin actualizar en el registro)
En marcha, sin reclutar	no aplica	Agalsidase Beta Long-Term Treatment Outcome for Fabry Disease Patients With IVS4 Mutation in Taiwan	sep 2026 (prevista, ya pasada: sin actualizar en el registro)
Reclutando pacientes	Fase 4	iGlarLixi · China Soli-CGMDiabetes tipo 2 (T2D)	sep 2026 (prevista, ya pasada: sin actualizar en el registro)
En marcha, sin reclutar	no aplica	Dupilumab · GLOBOSPINPrurigo nodular	sep 2026 (prevista, ya pasada: sin actualizar en el registro)
Aún sin reclutar	Fase 1	BelumosudilStudy to Compare the Plasma Concentration of Belumosudil Given as an Oral Suspension and as a Tablet to Healthy Adult Male Participants	sep 2026 (prevista, ya pasada: sin actualizar en el registro)
En marcha, sin reclutar	Fase 2	Amlitelimab · RIVER-ASTHMAAsma	sep 2026 (prevista, ya pasada: sin actualizar en el registro)
En marcha, sin reclutar	no aplica	Dupilumab · PROADAPDermatitis atopica	sep 2026 (prevista, ya pasada: sin actualizar en el registro)
En marcha, sin reclutar	Fase 2	balinatunfibA Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS)	sep 2026 (prevista, ya pasada: sin actualizar en el registro)
En marcha, sin reclutar	Fase 3	Itepekimab · CEREN-1Rinosinusitis cronica con polipos nasales	oct 2026 (prevista)
En marcha, sin reclutar	no aplica	Alglucosidase alfa GZ419829A Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD)	oct 2026 (prevista)
En marcha, sin reclutar	Fase 2	venglustat · LEAPVenglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 With Venglustat Monotherapy Extension	oct 2026 (prevista)
En marcha, sin reclutar	no aplica	TeplizumabDiabetes tipo 1	nov 2026 (prevista)
En marcha, sin reclutar	Fase 3	Itepekimab · CEREN-2Rinosinusitis cronica con polipos nasales	nov 2026 (prevista)
En marcha, sin reclutar	Fase 1/2	Pandemic flu H5 HA mRNA SD2…Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and Older	dic 2026 (prevista)
En marcha, sin reclutar	Fase 3	PCV21infecciones neumocócicas	dic 2026 (prevista)
Reclutando pacientes	Fase 2	SAR442970 · CHROMA CDEnfermedad de Crohn	dic 2026 (prevista)
Reclutando pacientes	Fase 2	SAR442970 · COLOR UCColitis ulcerosa	dic 2026 (prevista)
Reclutando pacientes	Fase 2	frexalimab · RESULTA Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease	dic 2026 (prevista)
Reclutando pacientes	Sin fase asignada	Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)Diabetes tipo 1	dic 2026 (prevista)
En marcha, sin reclutar	no aplica	Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During Pregnancy	dic 2026 (prevista)
Reclutando pacientes	Fase 3	PCV21Enfermedad de celulas falciformes	ene 2027 (prevista)
En marcha, sin reclutar	Fase 3	efanesoctocog alfa · XTEND-edHemofilia A	ene 2027 (prevista)
En marcha, sin reclutar	Fase 1/2	Investigational hMPVStudy of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older	ene 2027 (prevista)
Reclutando pacientes	Fase 2	Brivekimig · BRIGHTENHidradenitis supurativa	feb 2027 (prevista)
En marcha, sin reclutar	Fase 3	Itepekimab · CEREN-3Rinosinusitis cronica con polipos nasales	feb 2027 (prevista)
En marcha, sin reclutar	Fase 4	Dupilumab · ATLASAsma	mar 2027 (prevista)
En marcha, sin reclutar	no aplica	Dupilumab SAR231893 · GLOBOSTADObservational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)	mar 2027 (prevista)
Reclutando pacientes	Fase 1	H5 Flu Investigational Medical…Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age	abr 2027 (prevista)
En marcha, sin reclutar	Fase 3	Isatuximab SAR650984 · IMROZMieloma de celulas plasmaticas	abr 2027 (prevista)
En marcha, sin reclutar	Fase 2	Frexalimab · FABULINUSDiabetes tipo 1	abr 2027 (prevista)
En marcha, sin reclutar	Fase 4	dupilumab · PELISTAD-EX2dermatitis atópica	abr 2027 (prevista)
En marcha, sin reclutar	Fase 2	Brivekimig · T1D OBTAINDiabetes tipo 1	abr 2027 (prevista)
Reclutando pacientes	no aplica	FRAMEDermatitis atopica	may 2027 (prevista)
En marcha, sin reclutar	no aplica	A Longitudinal Study of Epstein-Barr Virus (EBV) Reactivation in Adults Aged 18 to 29 Years	may 2027 (prevista)
En marcha, sin reclutar	Fase 3	PCV21 vaccineInmunizacion neumococica	may 2027 (prevista)
En marcha, sin reclutar	Fase 1/2	Pentavalent Meningococcal ABCYW…Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants	may 2027 (prevista)
En marcha, sin reclutar	Fase 1/2	SAR402663Degeneracion macular asociada a la edad neovascular	may 2027 (prevista)
Reclutando pacientes	no aplica	Dupilumab · DERMIND-ADDermatitis atopica	may 2027 (prevista)
Reclutando pacientes	no aplica	Dupilumab · ProMEALA Non-interventional Observational Study to Assess Long-term Efficacy and Safety of Dupilumab for the Treatment of Patients (>= 12 Years) With Eosinophilic Esophagitis Under Real-world-conditions in Germany	jun 2027 (prevista)
Reclutando pacientes	Fase 3	DupilumabPrurito	jun 2027 (prevista)
En marcha, sin reclutar	Fase 4	Avalglucosidase alfaEnfermedad de deposito de glucogeno tipo II	jun 2027 (prevista)
Reclutando pacientes	Fase 3	riliprubart · VITALIZEPolineuropatia desmielinizante inflamatoria cronica	jul 2027 (prevista)
Reclutando pacientes	Fase 3	Frexalimab · FrexciteEsclerosis múltiple	jul 2027 (prevista)
Reclutando pacientes	Fase 3	Rilzabrutinib · LIBRAenfermedad de células falciformes	jul 2027 (prevista)
En marcha, sin reclutar	Fase 3	PCV21 vaccineInmunización neumocócica · Voluntarios sanos	ago 2027 (prevista)
Aún sin reclutar	Fase 4	BelumosudilEnfermedad cronica de injerto contra huesped	ago 2027 (prevista)
Reclutando pacientes	Fase 1/2	IsatuximabIsatuximab in Combination With Novel Agents in RRMM - Master Protocol	sep 2027 (prevista)
Reclutando pacientes	Fase 1/2	SAR446597A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration	oct 2027 (prevista)
Reclutando pacientes	Fase 3	DupilumabPrurigo nodular	oct 2027 (prevista)
Reclutando pacientes	Fase 3	rilzabrutinib · LUNA 4Trombocitopenia inmune	nov 2027 (prevista)
Aún sin reclutar	no aplica	Efluelda Tetra Pre-filled…Post-marketing Surveillance Study for the Safety of Efluelda Tetra Pre-filled Syringe.	dic 2027 (prevista)
Reclutando pacientes	Fase 1	SAR448501A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Relapsed/ Refractory B-Cell Non-Hodgkin Lymphoma	ene 2028 (prevista)
Reclutando pacientes	Fase 1	SAR447971SAR447971 First-in-human Study	feb 2028 (prevista)
Reclutando pacientes	Fase 1/2	Flu H5 egg pandemic low dose…Voluntarios sanos · Gripe	feb 2028 (prevista)
Reclutando pacientes	Fase 2	Sarilumab SAR153191 · SKYPSA Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)	mar 2028 (prevista)
Reclutando pacientes	Fase 2	Teplizumab · KIBOU-T1DDiabetes tipo 1	mar 2028 (prevista)
Aún sin reclutar	Fase 3	MenQuadfi®Infeccion meningococica · Voluntarios sanos	mar 2028 (prevista)
Reclutando pacientes	no aplica	Dupilumab · AD-BEASCUITSDermatitis atopica	mar 2028 (prevista)
Reclutando pacientes	Fase 4	Avalglucosidase alfaEnfermedad de almacenamiento de glucogeno tipo II · Enfermedad de Pompe	may 2028 (prevista)
Reclutando pacientes	Fase 1/2	RSV+HMPV vaccinePhase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older	may 2028 (prevista)
En marcha, sin reclutar	no aplica	Dupilumab · DUPILABDermatitis atopica	may 2028 (prevista)
Reclutando pacientes	no aplica	Meningococcal polysaccharideObservational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US)	may 2028 (prevista)
Reclutando pacientes	Fase 3	rilzabrutinib · LUMINA 3anemia hemolítica autoinmune	may 2028 (prevista)
En marcha, sin reclutar	no aplica	Efanesoctocog Alfa BIVV001Hemofilia A	jun 2028 (prevista)
Reclutando pacientes	Fase 3	Rilzabrutinib · RILIEFEnfermedad relacionada con inmunoglobulina G4	jun 2028 (prevista)
Reclutando pacientes	Fase 2	Bivalent RSV+HMPV protein…Phase 2b Study of a Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Protein Vaccine Candidate in Adults 60 Years of Age and Older	jul 2028 (prevista)
Aún sin reclutar	Fase 2	Acne mRNASafety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Moderate to Severe Acne	jul 2028 (prevista)
Reclutando pacientes	Fase 3	Duvakitug · SUNSCAPE-2colitis ulcerosa	sep 2028 (prevista)
Reclutando pacientes	Fase 2	Belumosudil · schoolROCKA Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)	sep 2028 (prevista)
En marcha, sin reclutar	Fase 3	Belumosudil · ROCKnrol-1enfermedad crónica de injerto contra hospedador	sep 2028 (prevista)
Reclutando pacientes	Fase 1/2	Sarilumab · OPALSArtritis reumatoide	oct 2028 (prevista)
Reclutando pacientes	Fase 1/2	Acne mRNA vaccineStudy to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne	nov 2028 (prevista)
Reclutando por invitación	Fase 2	Isatuximab intravenousInternational Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab	nov 2028 (prevista)
Reclutando por invitación	Fase 3	DupilumabSibilancias · Asma	dic 2028 (prevista)
Reclutando pacientes	Fase 4	Dupilumab · AEOLUSEnfermedad pulmonar obstructiva cronica	dic 2028 (prevista)
Reclutando pacientes	no aplica	Olipudase alfaA Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)	ene 2029 (prevista)
Reclutando pacientes	Fase 3	Belumosudil · ROCKaspireRechazo de trasplante pulmonar	ene 2029 (prevista)
Aún sin reclutar	no aplica	Efluelda® Pre-filled syringePost-marketing Surveillance Study for the Safety of Efluelda® Pre-filled Syringe	feb 2029 (prevista)
Reclutando pacientes	Fase 1/2	SAR446268 · BrAAVeA Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1	feb 2029 (prevista)
Reclutando pacientes	no aplica	AIRITYAsma	abr 2029 (prevista)
En marcha, sin reclutar	Fase 3	TolebrutinibEsclerosis multiple recurrente · Esclerosis multiple secundaria progresiva · Esclerosis multiple progresiva recurrente	abr 2029 (prevista)
Reclutando pacientes	Fase 3	Duvakitug · STARSCAPE-1Enfermedad de Crohn	may 2029 (prevista)
Reclutando pacientes	Fase 4	SarilumabPolimialgia reumatica	jun 2029 (prevista)
Reclutando pacientes	Fase 1/2	Acne mRNA vaccineStudy to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne	jun 2029 (prevista)
Reclutando pacientes	Fase 1	SAR448501A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases	jun 2029 (prevista)
Reclutando pacientes	no aplica	Cohort 1: Dupilumab · STRIDEThe Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry	jun 2029 (prevista)
Reclutando pacientes	no aplica	Dengue Tetravalent Vaccine · DNG00044Dengvaxia US Pregnancy Registry	jun 2029 (prevista)
Reclutando pacientes	no aplica	Dupilumab · ANEMOEPOC	jul 2029 (prevista)
Reclutando pacientes	Fase 3	Fitusiran · ATLAS-KIDSHemofilia	ago 2029 (prevista)
Reclutando pacientes	Fase 2/3	Frexalimab · FREXERARechazo de trasplante renal	ago 2029 (prevista)
Aún sin reclutar	Fase 3	Belumosudilenfermedad crónica del injerto contra el hospedador	sep 2029 (prevista)
Reclutando pacientes	no aplica	NirsevimabA Post-marketing Surveillance Study of Beyfortus (Nirsevimab) in Republic of Korea	sep 2029 (prevista)
Reclutando por invitación	Fase 3	Riliprubart Prefilled Pen · LTSPolineuropatia desmielinizante inflamatoria cronica	oct 2029 (prevista)
Reclutando pacientes	Fase 3	Lunsekimig · PERSEPHONEEnfermedad pulmonar obstructiva cronica	nov 2029 (prevista)
Reclutando pacientes	Fase 3	Lunsekimig · THESEUSEnfermedad pulmonar obstructiva cronica	nov 2029 (prevista)
En marcha, sin reclutar	Fase 1/2	SAR444836Fenilcetonuria	abr 2030 (prevista)
Reclutando por invitación	Fase 2	Lunsekimig · AIRPHRODITEAsma	ene 2031 (prevista)
Reclutando pacientes	Fase 1	SAR446523A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma	may 2031 (prevista)
En marcha, sin reclutar	Fase 2	Amlitelimab · ATLANTISOpen Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis	jun 2031 (prevista)
En marcha, sin reclutar	Fase 2	Blood draw for the laboratory…A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B	jun 2031 (prevista)
En marcha, sin reclutar	Fase 2	Long term follow up in all…Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration	ago 2033 (prevista)
Reclutando pacientes	no aplica	ARMADA-ADDermatitis atopica	ene 2034 (prevista)
Reclutando pacientes	no aplica	Fabry Disease Registry & Pregnancy Sub-registry	ene 2034 (prevista)
En marcha, sin reclutar	no aplica	PEDISTADObservational Evaluation of Atopic Dermatitis in Pediatric Patients	jul 2035 (prevista)
Reclutando pacientes	no aplica	TZIELDDiabetes tipo 1	ene 2037 (prevista)

Ver los 1.590 ya cerrados

Estado	Fase	Ensayo	Lectura de resultados
Retirado antes de empezar	Fase 3	Itepekimab · CEREN-4Rinosinusitis cronica con polipos nasales	oct 2027 (prevista)
Completado	Fase 3	Itepekimab · AERIFY-4EPOC	sep 2026 (real)
Retirado antes de empezar	Fase 2	BelumosudilSafety and Efficacy of Oral Belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander Male and Female Participants Aged 12 Years and Above With Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy	ago 2026 (prevista, ya pasada: sin actualizar en el registro)
Completado	Fase 3	Fitusiran · ATLAS-PEDSFitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B	ago 2026 (real)
Completado	no aplica	Alirocumab 150 mgLow-Density Lipoprotein Cholesterol Reduction With Alirocumab 150 mg Versus Inclisiran in Individuals Initiating Therapy in Routine Clinical Practice	jun 2026 (real)
Completado	no aplica	Nirsevimab Respiratory…An Observational Study to Assess Nirsevimab Immunization Rates in Eligible Infants During Their First RSV Season in the Czechia	jun 2026 (real)
Completado	no aplica	Dupilumab SAR231893 · REVEALAsma	jun 2026 (real)
Completado	Fase 4	iGlarLixiDiabetes tipo 2	jun 2026 (real)
Completado	Fase 3	DupilumabA Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2)	jun 2026 (real)
Interrumpido	no aplica	Dupilumab · DEDICATIONUrticaria cronica espontanea	jun 2026 (real)
Completado	Fase 1	BalinatunfibA Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.	may 2026 (real)
Completado	Fase 1/2	TrivalentGripe · Voluntarios sanos	may 2026 (real)
Completado	no aplica	Vakzimeter RSVRepeated Cross Sectional Surveillance Study To Determine the Respiratory Syncytial Virus (RSV) Immunization Rates in German Infants	may 2026 (real)
Completado	no aplica	Leflunomide · ARAVA PASSA Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi Arabia	may 2026 (real)
Completado	Fase 4	BelumosudilA Clinical Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belumosudil in Chinese Adolescents With cGVHD Who Have Had an Inadequate Response to Glucocorticoids or Other Systemic Therapies	may 2026 (real)
Completado	Fase 1/2	IIV-HDStudy of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older	abr 2026 (real)
Completado	no aplica	CANDIDObservational Study of Canadian Patients (6 Years or Older) Receiving Dupixent® for Moderate to Severe Atopic Dermatitis	abr 2026 (real)
Completado	Fase 1	SAR445229Voluntarios sanos	abr 2026 (real)
Completado	Fase 1/2	RIVStudy of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older	abr 2026 (real)
Completado	Fase 2	ItepekimabA Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps	mar 2026 (real)
Completado	Fase 1/2	Pandemic flu H5 mRNA vaccineStudy to Evaluate Safety and Immunogenicity of a Pandemic Flu H5 mRNA Vaccine in Healthy Adults Aged 18 Years and Older	mar 2026 (real)
Completado	Fase 1	parainfluenza virus type 3…Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older	mar 2026 (real)
Completado	Fase 3	Tadalafil 5 mg tablets with a…Actual Use Trial of Tadalafil 5 mg	mar 2026 (real)
Completado	Fase 1/2	RSVStudy of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate	feb 2026 (real)
Completado	no aplica	isatuximab SAR650984 · IONA-MMA Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)	feb 2026 (real)
Completado	Fase 2	Lunsekimig · AIRCULESAsma	feb 2026 (real)
Completado	no aplica	Vakzimeter FLURepeated Cross Sectional Surveillance Study To Determine the Influenza Vaccination Rates in German Participants	feb 2026 (real)
Completado	Fase 2	LunsekimigA Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis	feb 2026 (real)
Completado	no aplica	DTaP-IPV-Hep B-PRP-T combined…Post-marketing Surveillance Study for the Safety of a DTaP-IPV- HB-PRP~T Vaccine in Republic of Korea	ene 2026 (real)
Completado	no aplica	Real World and Epidemiology Study of Medically Attended Chlamydia Trachomatis Among Adults in Germany	dic 2025 (real)
Completado	Fase 3	Eliglustat GZ385660 · ELIKIDSSafety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3	dic 2025 (real)
Completado	Fase 3	Yellow fever vaccinePhase 3 Single Arm, Open Study on vYF in Adults	dic 2025 (real)
Completado	no aplica	Trivalent Recombinant Influenza…A Study to Assess Tolerability of the Trivalent Recombinant Vaccine in Individuals Aged 18 and Older Using the Vaccinees Perception of Injection Questionnaire	dic 2025 (real)
Interrumpido	Fase 1/2	SAR444200Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors	dic 2025 (real)
Completado	Fase 1	SAR446959Artrosis	dic 2025 (real)
Completado	Fase 1	TIV-HA Vaccine formulation 1 at…A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.	dic 2025 (real)
Completado	Fase 4	FASTStudy to Assess Safety and Efficacy of Fexofenadine Hydrochloride (HCL) + Pseudoephedrine HCL Fixed Dose Combination in Indian Male and Female Participants With Allergic Rhinitis (AR) Who Are 12 Years and Above	dic 2025 (real)
Interrumpido	Fase 3	RSVt Vaccine · PEARLEfficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers	dic 2025 (real)
Interrumpido	Fase 1/2	THOR-707 · HAMMERA Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)	dic 2025 (real)
Completado	no aplica	Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)	nov 2025 (real)
Completado	Fase 1	AmlitelimabAn Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substrates	nov 2025 (real)
Completado	Fase 3	Meningococcal PolysaccharideStudy of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa	nov 2025 (real)
Completado	Fase 3	MenACYW conjugate vaccineStudy on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers	nov 2025 (real)
Completado	Fase 3	Tolebrutinib · PERSEUSPrimary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)	nov 2025 (real)
Interrumpido	Fase 2	SAR444656 · ADVANTADermatitis atopica	oct 2025 (real)
Completado	Fase 1	RSVStudy to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years	oct 2025 (real)
Interrumpido	Fase 2	SAR444656 · ZENHidradenitis supurativa	oct 2025 (real)
Completado	Fase 2	Amlitelimab · HYDROA Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo	oct 2025 (real)
Completado	no aplica	Alirocumab · OPTIMUS-IMPACTAlirocumab and Ischemic Risk in Atherosclerotic Cardiovascular Disease (ASCVD)	sep 2025 (real)
Completado	no aplica	Sodium valporate · DEPAKINE PASSA Study of the Effectiveness of Risk Minimization Measures Related to Depakine® (Sodium Valproate) in Saudi Arabia	sep 2025 (real)
Interrumpido	no aplica	efanesoctocog alfa · ACTIVIIITYHemofilia A	sep 2025 (real)
Interrumpido	Fase 3	RSVt vaccine · CORALCo-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers	sep 2025 (real)
Completado	Fase 2	ItepekimabA Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis	sep 2025 (real)
Completado	Fase 3	Amlitelimab · SHOREA Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids	ago 2025 (real)
Interrumpido	Fase 1/2	SAR443579Leucemia mieloide aguda	ago 2025 (real)
Completado	Fase 2	SAR447537 · ELEVAATEStudy of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema	ago 2025 (real)
Completado	no aplica	Teplizumab · TEPLI-REALDiabetes tipo 1	ago 2025 (real)
Completado	Fase 3	Amlitelimab · COAST 1A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis	jul 2025 (real)
Completado	no aplica	BEARBEYFORTUS™ (Nirsevimab) Effectiveness Against Medically-Attended RSV Events in Infants (BEAR Study)	jun 2025 (real)
Completado	Fase 2	SAR441566 · SPECIFI-RAArtritis reumatoide	jun 2025 (real)
Interrumpido	Fase 1/2	SAR443579First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)	jun 2025 (real)
Interrumpido	Fase 3	Low Dose · OPALA Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers	jun 2025 (real)
Interrumpido	Fase 1	SAR445514A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA)	may 2025 (real)
Completado	Fase 3	Itepekimab SAR440340 · AERIFY-2EPOC	abr 2025 (real)
Completado	Fase 3	Itepekimab SAR440340 · AERIFY-1EPOC	abr 2025 (real)
Completado	Fase 2	Olipudase alfaA Study to Evaluate Safety and Tolerability of Olipudase Alfa in Pediatric and Adult Participants With Acid Sphingomyelinase Deficiency (ASMD) Who Completed the DFI12712 or the LTS13632 Study in France	abr 2025 (real)
Completado	Fase 3	DupilumabAsma	abr 2025 (real)
Completado	Fase 2	Itepekimab SAR440340 · AERIFY-3EPOC	mar 2025 (real)
Interrumpido	Fase 1	SAR445088Safety and Tolerability Study in Adults With Cold Agglutinin Disease Previously Treated With SAR445088 or Never Treated With SAR445088	mar 2025 (real)
Completado	Fase 1	Trivalent-Darwin influenza…Gripe · Voluntarios sanos	mar 2025 (real)
Completado	Fase 1	RSVStudy of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older	feb 2025 (real)
Interrumpido	Fase 2	AmlitelimabProof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidradenitis Suppurativa	feb 2025 (real)
Completado	Fase 3	High-Dose trivalent influenza…Gripe	ene 2025 (real)
Completado	no aplica	Mucopolysaccharidosis I (MPS I) Registry	dic 2024 (real)
Interrumpido	Fase 3	venglustat GZ402671 · AMETHISTA Multinational, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, and Safety of Venglustat in Late-onset GM2	dic 2024 (real)
Completado	Fase 3	Dupilumab SAR231893 · AIMSDupilumab in Allergic Fungal Rhinosinusitis (AFRS)	dic 2024 (real)
Completado	no aplica	Sarilumab SAR153191An Observational Study on Sarilumab-exposed Pregnancies	dic 2024 (real)
Completado	Fase 2	TolebrutinibEsclerosis multiple recurrente	nov 2024 (real)
Completado	no aplica	OPPUSA Non-Interventional National Study in Pediatric Patients With Unexplained Enlarged Spleen	nov 2024 (real)
Interrumpido	Fase 2	SAR443820Esclerosis multiple	nov 2024 (real)
Completado	Fase 2	SAR441566 · SPECIFI-PSOPsoriasis	nov 2024 (real)
Interrumpido	Fase 1	SAR439459Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)	nov 2024 (real)
Completado	Fase 3	DupilumabUrticaria cronica espontanea	nov 2024 (real)
Interrumpido	Fase 1/2	Amcenestrant · AMEERA-1Cancer de mama	nov 2024 (real)
Completado	Fase 4	AGALSIDASE BETA · SHORTENA Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme	oct 2024 (real)
Completado	no aplica	DUPIAZAAsma	oct 2024 (real)
Completado	Fase 2	rilzabrutinibOpen Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease Participants	oct 2024 (real)
Completado	Fase 2	Amlitelimab · TIDE-asthmaAsma	oct 2024 (real)
Completado	Fase 4	MenACYW conjugate vaccineStudy of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy	sep 2024 (real)
Completado	Fase 3	DupilumabDupilumab in Chinese Adult Participants With CRSwNP	sep 2024 (real)
Interrumpido	Fase 3	VAT00008COVID-19	ago 2024 (real)
Completado	Fase 3	Tolebrutinib · HERCULESNonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES)	ago 2024 (real)
Completado	Fase 1	MAGNE-B6 Oral SolutionVoluntarios sanos	ago 2024 (real)
Completado	Fase 2	SAR442970 · HS OBTAINHidradenitis supurativa	ago 2024 (real)
Completado	Fase 3	Dupilumab SAR231893Urticaria cronica espontanea	ago 2024 (real)
Completado	Fase 2	PRV-015 · PROACTIVEPRV-015 in Gluten-free Diet Non-responsive Celiac Disease	jul 2024 (real)
Completado	Fase 4	ALGLUCOSIDASE ALFA · APOLLO-LOPDStudy to Evaluate Efficacy and Safety in Chinese Patients With Late Onset Pompe Disease With Alglucosidase Alfa Treatmen	jul 2024 (real)
Completado	no aplica	Prospective Surveillance of Respiratory Syncytial Virus Disease in Infants and ToddlersInfeccion por virus respiratorio sincitial	jul 2024 (real)
Completado	Sin fase asignada	TW CES RCTDiabetes tipo 2	jun 2024 (real)
Completado	no aplica	A Study in Male and Female Adult Participants With Chronic Rhinosinusitis With Nasal Polyps In the Greater Gulf Region	jun 2024 (real)
Completado	Fase 2	Belumosudil 200 mg QDExtended Treatment and Follow-up of Subjects Treated With Belumosudil in Study KD025-208 or Study KD025-213	jun 2024 (real)
Interrumpido	Fase 2	PRV-3279 · PREVAIL-2Lupus eritematoso sistemico	may 2024 (real)
Completado	Fase 1	Fexofenadine HCl Coated tabletVoluntarios sanos	may 2024 (real)
Completado	Fase 1	Rilzabrutinib crystalline formA Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants	abr 2024 (real)
Completado	no aplica	Burden of Respiratory Syncytial Virus (RSV) in Children in Sweden (BRICS): A Retrospective Study in SwedenInfeccion por virus respiratorio sincitial	abr 2024 (real)
Interrumpido	Fase 1/2	VociprotafibSafety and Efficacy Study of Vociprotafib (SAR442720) in Combination With Other Agents in Advanced Malignancies	abr 2024 (real)
Completado	Fase 1/2	Quadrivalent Influenza mRNA…Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adult Participants18 Years of Age and Older	abr 2024 (real)
Completado	Fase 1/2	Quadrivalent Influenza mRNA…Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older	mar 2024 (real)
Completado	Fase 1	isatuximab SAR650984 IVMieloma multiple	mar 2024 (real)
Completado	Fase 3	NirsevimabStudy of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of Life	mar 2024 (real)
Completado	Fase 1	H3 mRNASubstudy 01 - Safety and Immunogenicity of One Monovalent Modified mRNA Vaccine Encoding Influenza Hemagglutinin With LNP, in Adult Participants Aged 18 to 49 Years and 60 Years and Above	mar 2024 (real)
Completado	no aplica	PEDIASTHMAAsma	mar 2024 (real)
Interrumpido	Fase 2	SAR408701 · CARMEN-LC05Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed in Patients With NSQ NSCLC	mar 2024 (real)
Interrumpido	Fase 2	SAR443820 · HIMALAYAEsclerosis lateral amiotrofica	mar 2024 (real)
Interrumpido	Fase 2	Tusamitamab ravtansine · CARMEN-LC06Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEA	mar 2024 (real)
Completado	Fase 3	Dupilumab SAR231893 · NOTUSEPOC	feb 2024 (real)
Interrumpido	Fase 1	SAR445419A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid Leukemia	feb 2024 (real)
Interrumpido	Fase 2	tusamitamab ravtansine · CARMEN-BT01Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors	feb 2024 (real)
Interrumpido	Fase 4	agalsidase betaStudy of the Effects of Fabrazyme Treatment on Lactation and Infants	feb 2024 (real)
Completado	Fase 2	RilzabrutinibAsma	feb 2024 (real)
Completado	no aplica	HomERTA Study to Assess the Safety of Myozyme® and of Aldurazyme® in Male and Female Participants of Any Age Group With Pompe Disease or With Mucopolysaccharidosis Type I (MPS I) in a Home-care Setting	ene 2024 (real)
Completado	Fase 1	VenglustatA Study in Adults to Investigate the Impact of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Venglustat Compared to Participants With Normal Hepatic Function	ene 2024 (real)
Completado	Fase 4	Dupilumab · BALISTAD-CNDupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China	ene 2024 (real)
Completado	Fase 1/2	Quadrivalent Influenza mRNA…Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and Older	ene 2024 (real)
Interrumpido	Fase 1	SAR443216 IVDose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors	ene 2024 (real)
Completado	Fase 1	mRNA NA vaccineStudy to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older	ene 2024 (real)
Completado	no aplica	PERSISTENTA Study of an Existing Database to Assess the Treatment Persistence to Basal Insulin in Type 2 Diabetes Mellitus Patients in a Structured Patient Education Program in India	dic 2023 (real)
Completado	Fase 4	Dupilumab · PELISTAD CNDermatitis atopica	dic 2023 (real)
Interrumpido	no aplica	Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin	dic 2023 (real)
Completado	no aplica	Quadrivalent Influenza VaccineSafety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2023/24	dic 2023 (real)
Interrumpido	no aplica	A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness	dic 2023 (real)
Completado	no aplica	Study Based on Electronic Health RecOrds to Identify Patients at High-risk of Fabry DiseasE (HOPE Fabry)	dic 2023 (real)
Completado	Fase 1	SAR444336Voluntarios sanos	dic 2023 (real)
Interrumpido	Fase 2	BelumosudilEfficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy	dic 2023 (real)
Interrumpido	Fase 1	KD033Tumor solido	dic 2023 (real)
Completado	Fase 1	ORG101 · OREASafety, Tolerability, and Immunogenicity of ORI-A-ce001 for the Treatment of Acne Vulgaris	nov 2023 (real)
Completado	Fase 3	Quadrivalent Recombinant…Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) in Participants 9 Through 49 Years of Age.	oct 2023 (real)
Completado	Fase 4	Cerezyme® · SEEDStudy to Evaluate Efficacy and Safety of Imiglucerase Treatment in Chinese Patients With Gaucher Disease Type Ⅲ	oct 2023 (real)
Interrumpido	Fase 3	SAR408701 · CARMEN-LC03SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer Patients	sep 2023 (real)
Interrumpido	Fase 2	THOR-707A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205]	sep 2023 (real)
Completado	Fase 2	GZ402665A Long-Term Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency	sep 2023 (real)
Completado	Fase 2	Pneumococcal Conjugate Vaccine…Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants	ago 2023 (real)
Interrumpido	Fase 1	Tusamitamab ravtansine · TusaRav-QTEffect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors	ago 2023 (real)
Interrumpido	Fase 4	Insulin glargine 300 U · TRENTDiabetes tipo 2 · Insuficiencia renal	jul 2023 (real)
Completado	Fase 2	THOR-707A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)	jul 2023 (real)
Completado	Fase 4	LaronidaseChina Post-marketing Surveillance (PMS) Study of Aldurazyme®	jul 2023 (real)
Interrumpido	Fase 2	PembrolizumabCarcinoma escamoso de cabeza y cuello	jul 2023 (real)
Interrumpido	Fase 2	THOR-707A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202)	jul 2023 (real)
Completado	Fase 1	SAR441566Artritis reumatoide	jul 2023 (real)
Completado	Fase 2/3	SARS-CoV-2 recombinant protein…COVID-19	jun 2023 (real)
Completado	no aplica	A Study in Male and Female Adult Patients With Atopic Dermatitis Treated With Dupilumab in TaiwanDermatitis atopica	jun 2023 (real)
Interrumpido	Fase 2	Isatuximab SAR650984Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia (wAIHA)	jun 2023 (real)
Completado	Fase 4	Dupilumab · VESTIGEAsma	jun 2023 (real)
Completado	Fase 2	RilzabrutinibDermatitis atopica	jun 2023 (real)
Completado	Fase 1	isatuximab SAR650984SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM Patients	jun 2023 (real)
Completado	no aplica	TeriflunomideEsclerosis multiple	jun 2023 (real)
Completado	Fase 1	Amlitelimab DP1Voluntarios sanos	may 2023 (real)
Completado	Fase 3	MenACYW conjugate vaccineImmunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe	may 2023 (real)
Completado	Sin fase asignada	A Prospective and Retrospective Cohort Study in Patients With Chronic Forms of Acid Sphingomyelinase Deficiency (ASMD)	may 2023 (real)
Completado	Fase 1	Humanized anti-Factor Bb…Hemoglobinuria paroxistica nocturna	may 2023 (real)
Completado	Fase 1/2	RSV vaccine formulation 1 · VAD00001Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers	abr 2023 (real)
Completado	Fase 1/2	Isatuximab SAR650984Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients	abr 2023 (real)
Completado	Fase 4	Insulin glargine · Soli-CGMDiabetes tipo 2	mar 2023 (real)
Completado	no aplica	CYD-TDV Dengue VaccineObservational Study to Evaluate the Safety of CYD Tetravalent Dengue Vaccine (CYD-TDV) in Pregnant Women and Their Offsprings Inadvertently Exposed During Pregnancy	mar 2023 (real)
Completado	no aplica	AD-impaCTA Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf Countries	mar 2023 (real)
Completado	Fase 3	Meningococcal polysaccharide · MET41Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers	mar 2023 (real)
Completado	Fase 4	Insulin glargine 300 U · INITIATIONDiabetes tipo 2	feb 2023 (real)
Interrumpido	Fase 3	Tolebrutininb · URSAEfficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis	feb 2023 (real)
Completado	Fase 1/2	Panblok + MF59 Dose 1Gripe · Voluntarios sanos	feb 2023 (real)
Completado	Fase 1	Influenza Hemagglutinin mRNA…Safety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adult Participants 18 Years of Age and Older	feb 2023 (real)
Completado	no aplica	MARSNon-interventional Study on the Monthly Administration of 300 mg AliRocumab (PRALUENT®) With the 2 ml SYDNEY Auto-injector	feb 2023 (real)
Completado	Fase 1	SAR441566Psoriasis	feb 2023 (real)
Completado	Fase 3	Dupilumab SAR231893 · BOREASEPOC	feb 2023 (real)
Completado	Fase 2	RilzabrutinibA Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)	ene 2023 (real)
Completado	Fase 3	Meningococcal polysaccharide · MET55Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, Children, and Toddlers in India and Healthy Adolescents and Children in the Republic of South Africa	ene 2023 (real)
Completado	Fase 2	CYD Dengue VaccineSafety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults	ene 2023 (real)
Completado	no aplica	A Study to Assess the Reliability/Feasibility of Using Emerald Touchless Sensor for Scratching and Sleep Quantification in a Subset of Participants From PEDISTAD Study (OBS15333; NCT03687359)	ene 2023 (real)
Completado	Fase 2	PRN473Dermatitis atopica	dic 2022 (real)
Completado	no aplica	Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine	dic 2022 (real)
Completado	Fase 4	Dupilumab SAR231893Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52)	dic 2022 (real)
Interrumpido	Fase 4	LaronidaseA Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants	dic 2022 (real)
Completado	Fase 4	plerixafor + G-CSFMobilization of Stem Cells With AMD3100 (Plerixafor) in Combination With G-CSF in Multiple Myeloma Patients	dic 2022 (real)
Completado	Fase 3	Meningococcal polysaccharideImmunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom	dic 2022 (real)
Completado	Fase 1	efanesoctocog alfaTo Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD)	dic 2022 (real)
Completado	no aplica	Quadrivalent Influenza VaccineSafety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2022/23	nov 2022 (real)
Completado	Fase 3	ITP FIRTECH · IRPATCHEfficacy and Safety of FIRTECH in Patients With Mild to Moderate Acute Low Back Pain	nov 2022 (real)
Interrumpido	Fase 1/2	isatuximab SAR650984Linfoma	nov 2022 (real)
Completado	no aplica	REACT-CEMICarcinoma escamoso cutaneo	nov 2022 (real)
Completado	Fase 1	BelumosudilA Study to Assess the Effect of Oral Belumosudil on Inhibition of Various Proteins in the Fed State in Healthy Male Subjects	oct 2022 (real)
Interrumpido	Fase 3	Amcenestrant · AMEERA-6Cancer de mama	oct 2022 (real)
Interrumpido	Fase 2	lademirsen · HERAStudy of Lademirsen (SAR339375) in Patients With Alport Syndrome	sep 2022 (real)
Interrumpido	Fase 2	Isatuximab · ISAKIDSLeucemia linfoblastica aguda · Leucemia mieloide aguda	sep 2022 (real)
Completado	Fase 4	Dupilumab SAR231893 · PELISTADDupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis	sep 2022 (real)
Completado	Fase 3	Quadrivalent Recombinant…Study Describing the Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus a Licensed Quadrivalent-inactivated Influenza Vaccine (IIV4) (Fluarix® Quadrivalent) in Participants 18 Years of Age and Older in South Korea	sep 2022 (real)
Completado	Fase 1	SAR442085First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma	ago 2022 (real)
Interrumpido	Fase 2	BelumosudilKD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis	ago 2022 (real)
Interrumpido	Fase 1	SAR441000A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors	jul 2022 (real)
Completado	Fase 1	SAR443820Esclerosis lateral amiotrofica · Voluntarios sanos	jul 2022 (real)
Completado	Fase 4	Dupilumab · DIFFEREN-STADDupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis	jun 2022 (real)
Completado	Fase 3	Rosuvastatin · ROZELHipercolesterolemia	jun 2022 (real)
Completado	Fase 1	KD025Insuficiencia hepatica	jun 2022 (real)
Completado	no aplica	FluorouracilResection Observatory	may 2022 (real)
Completado	Fase 1	tolebrutinibStudy to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Mild Hepatic Impairment Compared to Participants With Normal Hepatic Function	may 2022 (real)
Completado	Fase 1	TolebrutinibEsclerosis multiple	may 2022 (real)
Completado	Fase 3	Dupilumab SAR231893Asma	may 2022 (real)
Interrumpido	Fase 1	amcenestrantPharmacokinetics of Amcenestrant in Female Hepatic Impaired Participants as Compared to Participants With Normal Hepatic Function	may 2022 (real)
Completado	Fase 4	TERIFLUNOMIDE HMR1726 · SAFEEsclerosis multiple recurrente	may 2022 (real)
Completado	Fase 2	BelumosudilA Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease	may 2022 (real)
Interrumpido	Fase 2	Belumosudil · dcSSCEfficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis	may 2022 (real)
Completado	no aplica	A Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668	abr 2022 (real)
Completado	Fase 2	Sarilumab · SKYPPAn Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)	abr 2022 (real)
Completado	Fase 3	Meningococcal polysaccharide · MEQ00063Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) in Older Adults in Turkey and Lebanon	mar 2022 (real)
Completado	Fase 1/2	MRT5005 · RESTORE-CFFibrosis quistica	mar 2022 (real)
Completado	Fase 1	Itepekimab AIEPOC	mar 2022 (real)
Completado	Fase 3	Dupilumab SAR231893Asma	feb 2022 (real)
Completado	Fase 3	Meningococcal Polysaccharide · MET33Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico	feb 2022 (real)
Interrumpido	Fase 2	Amcenestrant · AMEERA-3Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer	feb 2022 (real)
Completado	Fase 2	Quadrivalent Inactivated…Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 Vaccine	feb 2022 (real)
Completado	no aplica	VaxigripTetra®Gripe	feb 2022 (real)
Completado	Fase 1	lenalidomideStudy of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalidomide + Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Transplant or No Intent for Immediate Transplantation	ene 2022 (real)
Completado	Fase 2	TesevatinibStudy of the Efficacy and Safety of Tesevatinib in Subjects With ADPKD	ene 2022 (real)
Completado	Fase 3	Fitusiran · ATLAS-PPXA Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis	ene 2022 (real)
Completado	Fase 3	isatuximab SAR650984 · IKEMAMultinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients	ene 2022 (real)
Completado	Fase 1	SAR442501A First-in-human Single and Repeated Dose Escalation Study of SAR442501 in Healthy Adults Subjects	ene 2022 (real)
Completado	Fase 1	BIVV020A Safety and Tolerability Study of BIVV020 in Adults With Cold Agglutinin Disease	ene 2022 (real)
Completado	Fase 3	Dupilumab SAR231893Dermatitis atopica	dic 2021 (real)
Completado	Fase 3	sutimlimab · CadenzaA Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion	dic 2021 (real)
Completado	Fase 1	IsatuximabA Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma	dic 2021 (real)
Completado	Fase 1	Efanesoctocog alfaHemofilia A	nov 2021 (real)
Completado	Fase 4	alglucosidase alfaGrowth and Development Study of Alglucosidase Alfa	nov 2021 (real)
Completado	no aplica	AlemtuzumabEsclerosis multiple	nov 2021 (real)
Completado	Fase 1/2	CoV2 preS dTM-AF03Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older	nov 2021 (real)
Completado	Fase 3	Dupilumab SAR231893Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME)	nov 2021 (real)
Completado	Fase 4	DupilumabDermatitis atopica	oct 2021 (real)
Completado	Fase 3	BIVV009A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion (Cardinal Study)	oct 2021 (real)
Completado	no aplica	Effectiveness of Adacel Vaccination in Pregnancy at Preventing Pertussis in Infants < 2 Months of Age in the United States	oct 2021 (real)
Completado	Fase 1	FBP00004Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult Subjects	sep 2021 (real)
Completado	Fase 4	Insulin glargine · inRangeDiabetes tipo 1	sep 2021 (real)
Completado	Fase 1	SAR443820A Study in Healthy Adult Male & Female Participants to Assess the Amount of the Study Medicine (SAR443820) Absorbed by the Body, When Given Orally in Fasted Condition as a Tablet Versus as a Capsule (Part 1) and When Given Orally as a Tablet in Fasted Condition Versus as a Tablet After Food (Part 2)	sep 2021 (real)
Retirado antes de empezar	Fase 2	SAR425899 · RestoreAssessment of the Safety and Effect of SAR425899 Versus Placebo for the Treatment of Non-alcoholic Fatty Liver Disease	ago 2021 (prevista, ya pasada: sin actualizar en el registro)
Completado	Fase 1	SAR443820Single & Multiple Ascending Dose Study of SAR443820 in Healthy Adult Participants	jul 2021 (real)
Interrumpido	Fase 3	Venglustat GZ402671 · STAGED-PKD-EXTLong-term Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With Venglustat	jul 2021 (real)
Completado	Fase 4	TERIFLUNOMIDE · TERI-PKEsclerosis multiple	jul 2021 (real)
Completado	Fase 1	Yellow fever vaccine · VYF01Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in Adults	jun 2021 (real)
Completado	Fase 3	Purified vero rabies vaccineStudy of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adults in Thaïland	jun 2021 (real)
Completado	Fase 4	Dupilumab SAR231893 · BALISTADDermatitis atopica	jun 2021 (real)
Interrumpido	Fase 3	Quadrivalent influenza vaccine · QHD00014Gripe	jun 2021 (real)
Completado	Fase 1	Isatuximab SAR650984 · PomdeSARSAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients	may 2021 (real)
Interrumpido	Fase 3	Sarilumab SAR153191Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica	may 2021 (real)
Completado	Fase 2/3	CaplacizumabA Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)	may 2021 (real)
Interrumpido	Fase 1	HSV 2 Formulation 1 · HSV15Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2	may 2021 (real)
Completado	no aplica	SMSA National Study in Patients With Unexplained Splenomegaly	abr 2021 (real)
Completado	no aplica	alglucosidase alfaAlglucosidase Alfa Pompe Safety Sub-Registry	abr 2021 (real)
Completado	Fase 1	RilzabrutinibVoluntarios sanos	abr 2021 (real)
Completado	Fase 2/3	Olipudase alfa · ASCENDEfficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency	mar 2021 (real)
Completado	Fase 4	RASBURICASE SR29142 · RAISELinfoma	mar 2021 (real)
Completado	Fase 3	Insulin glargine · Lixilan-O-APDiabetes tipo 2	mar 2021 (real)
Completado	Fase 3	DTwP-HepB-Hib-IPV hexavalent…Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand	feb 2021 (real)
Completado	Fase 1	BIVV009 6.5 gramsA Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP)	feb 2021 (real)
Completado	Fase 3	High-Dose Quadrivalent…Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Taiwanese Adults 65 Years of Age and Older	feb 2021 (real)
Interrumpido	Fase 1/2	SAR440234First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome	feb 2021 (real)
Completado	Fase 3	fitusiranA Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors	ene 2021 (real)
Interrumpido	Fase 4	TEICOPLANINEfficacy and Safety of Teicoplanin in CDAD	ene 2021 (real)
Completado	Fase 3	Alirocumab SAR236553An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia	ene 2021 (real)
Completado	Fase 3	High-Dose Quadrivalent…Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Japanese Adults 60 Years of Age and Older	ene 2021 (real)
Completado	Fase 3	SAR153191Artritis reumatoide	dic 2020 (real)
Completado	Fase 4	ALGLUCOSIDASE ALFA · APOLLO-IOPDEvaluate Efficacy and Safety in Chinese Patients With Infantile-Onset Pompe Disease With One Year Alglucosidase Alfa Treatment	dic 2020 (real)
Completado	Fase 3	VRVg-2Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults	dic 2020 (real)
Completado	Fase 4	Fluzone Quadrivalent vaccineAnnual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2020-2021 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively	dic 2020 (real)
Interrumpido	Fase 2	venglustat GZ · MOVES-PDEnfermedad de Parkinson	dic 2020 (real)
Completado	Fase 4	Alogliptin · ACADEMICDiabetes tipo 2	dic 2020 (real)
Interrumpido	Fase 3	Efpeglenatide · AMPLITUDE-ODiabetes tipo 2	dic 2020 (real)
Completado	Fase 3	Insulin glargine · Lixilan-L-CNDiabetes tipo 2	dic 2020 (real)
Completado	Fase 3	Quadrivalent Influenza VaccineGripe	dic 2020 (real)
Completado	Fase 3	fitusiran · ATLAS-INHA Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors	nov 2020 (real)
Interrumpido	Fase 3	Sarilumab SAR153191Evaluation of Efficacy and Safety of Sarilumab in Patients With GCA	nov 2020 (real)
Interrumpido	Fase 3	Efpeglenatide SAR439977 · AMPLITUDE-LDiabetes tipo 2	nov 2020 (real)
Completado	Fase 4	alglucosidase alfa · PAPAYAPharmacokinetics of Alglucosidase Alfa in Patients With Pompe Disease	nov 2020 (real)
Completado	Fase 3	Meningococcal PolysaccharideStudy of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age	nov 2020 (real)
Interrumpido	Fase 1	Amcenestrant · AMEERA-2Cancer de mama	oct 2020 (real)
Completado	Fase 3	INSULIN GLARGINE · LixilanOne CANDiabetes tipo 2	oct 2020 (real)
Completado	Fase 3	Meningococcal polysaccharideStudy on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to Two Meningococcal Reference Vaccines in European Toddlers	oct 2020 (real)
Interrumpido	Fase 3	Efpeglenatide · AMPLITUDE-DDiabetes tipo 2	oct 2020 (real)
Completado	Fase 4	INSULIN GLARGINE · ARTEMIS-DMDiabetes tipo 2	sep 2020 (real)
Completado	Fase 3	Meningococcal polysaccharideStudy to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4)	sep 2020 (real)
Completado	Fase 1	Isatuximab SAR650984Mieloma multiple	sep 2020 (real)
Completado	Fase 3	Dupilumab · VOYAGEAsma	ago 2020 (real)
Completado	Fase 3	Sarilumab SAR153191Sarilumab COVID-19	jul 2020 (real)
Completado	Fase 4	alemtuzumab GZ402673 · TOPAZPhase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409	jul 2020 (real)
Completado	Fase 1	TolebrutinibEsclerosis multiple	jul 2020 (real)
Completado	Fase 4	INSULIN GLARGINE · SWITCHDiabetes tipo 2	jun 2020 (real)
Interrumpido	Fase 1	PRN1371A Dose Escalation Study in Solid Tumors and a Dose Expansion Study of PRN1371 in Adult Patients With Metastatic Urothelial Carcinoma	jun 2020 (real)
Completado	no aplica	Vandetanib 300 mg · Caprelsa104Observational Study to Evaluate Vandetanib in RET -/+ Patients With Metastatic Medullary Thyroid Cancer	jun 2020 (real)
Interrumpido	Fase 3	Quadrivalent Influenza VaccineStudy to Evaluate the Effectiveness of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Adults 65 Years of Age and Older	may 2020 (real)
Interrumpido	Fase 1	Hydroxychloroquine SAR321068COVID-19	may 2020 (real)
Completado	Fase 4	rFVIIIFcA Study to Evaluate Efficacy of rFVIIIFc for Immune Tolerance Induction (ITI) in Severe Hemophilia A Participants With Inhibitors Undergoing the First ITI Treatment (verITI-8 Study)	may 2020 (real)
Retirado antes de empezar	Fase 2	ALX-0171 Dose 1Efficacy and Safety of ALX-0171 in Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients Who Present With Respiratory Syncytial Virus (RSV) Infection	may 2020 (prevista, ya pasada: sin actualizar en el registro)
Interrumpido	Fase 3	sotagliflozinDiabetes tipo 2	abr 2020 (real)
Completado	Fase 2	CYD Dengue VaccineImmunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age	abr 2020 (real)
Interrumpido	Fase 3	sotagliflozinDiabetes tipo 2	abr 2020 (real)
Completado	Fase 1	SAR441344Voluntarios sanos	abr 2020 (real)
Completado	Fase 3	Meningococcal PolysaccharideStudy to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49	abr 2020 (real)
Completado	Fase 3	Purified vero rabies vaccine · VRV12Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines, Given in a Pre-exposure Regimen to Children and Adults and as Single Booster Dose to a Subset of Adults	mar 2020 (real)
Completado	Fase 3	Avalglucosidase alfa · COMETStudy to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease	mar 2020 (real)
Completado	no aplica	DNG00042Study on Prescribers' Knowledge and Understanding of Safety Messages Following Dengvaxia® Product Information Update	mar 2020 (real)
Interrumpido	Fase 4	Myozyme®Immune Tolerance Induction Study	feb 2020 (real)
Completado	Fase 3	Alirocumab SAR236553Hipercolesterolemia	feb 2020 (real)
Completado	Fase 3	DupilumabDermatitis atopica	feb 2020 (real)
Completado	Fase 1	LixisenatideDiabetes tipo 2	ene 2020 (real)
Completado	Fase 3	Standard-Dose influenza virus…Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Europeans Adults 60 Years of Age and Older	ene 2020 (real)
Completado	Fase 2	SAR442168Esclerosis multiple recurrente	ene 2020 (real)
Completado	Fase 1	SAR442168Esclerosis multiple	dic 2019 (real)
Completado	no aplica	VaxigripTetra inj.Gripe	dic 2019 (real)
Completado	Fase 4	LEMTRADA-ITPEsclerosis multiple	dic 2019 (real)
Interrumpido	Fase 3	CYD Dengue VaccineStudy of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects	dic 2019 (real)
Completado	Fase 1/2	Olipudase alfa · ASCEND-PedsSafety, Tolerability, PK, and Efficacy Evaluation of Repeat Ascending Doses of Olipudase Alfa in Pediatric Patients <18 Years of Age With Acid Sphingomyelinase Deficiency	dic 2019 (real)
Completado	Fase 4	START-DCDA Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transplant	nov 2019 (real)
Completado	Fase 2	ArtefenomelStudy to Investigate the Clinical and Parasiticidal Activity and Pharmacokinetics of Different Doses of Artefenomel and Ferroquine in Patients With Uncomplicated Plasmodium Falciparum Malaria	nov 2019 (real)
Completado	Fase 3	Teriflunomide · TERIKIDSEsclerosis multiple	oct 2019 (real)
Completado	Fase 2	QHD04Gripe	oct 2019 (real)
Completado	no aplica	Acne Vulgaris Related Microbiology and SerologyAcne vulgar	sep 2019 (real)
Interrumpido	Fase 2	Ferroquine SSR97193 · FALCITo Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine and Artefenomel in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria	sep 2019 (real)
Completado	Fase 3	rFVIIIFcHemofilia A	sep 2019 (real)
Completado	no aplica	Quadrivalent Influenza VaccineSanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry	sep 2019 (real)
Completado	Fase 3	rFIXFc · PUPs B-LONGStudy to Determine the Safety and Efficacy of rFIXFc in Previously Untreated Males With Severe Hemophilia B	ago 2019 (real)
Completado	Fase 1	Insulin Lispro SAR342434Diabetes tipo 1	ago 2019 (real)
Completado	Fase 1	SotagliflozinDiabetes	ago 2019 (real)
Interrumpido	Fase 1/2	SAR422459Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular Degeneration	ago 2019 (real)
Completado	Fase 4	SARILUMAB · SariPROArtritis reumatoide	jul 2019 (real)
Completado	no aplica	Insulin glargine · ATOSTwelve -Month Study Observing How Insulin-naïve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo® After Oral Antidiabetic Drug Failure, the Side Effect of Toujeo®, and The Cost.	jun 2019 (real)
Completado	Fase 4	MeningococcalPostmarketing Surveillance Study for Use of Menactra® in the Republic of Korea	jun 2019 (real)
Completado	Fase 1	Shz QIV 0.25 mLSafety of a Single Dose or Two Doses of Shenzhen Quadrivalent Influenza Vaccine	jun 2019 (real)
Completado	Fase 1	RG012A Study of RG-012 in Subjects With Alport Syndrome	may 2019 (real)
Completado	Fase 1	Glucopyranosyl Lipid AA Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients	may 2019 (real)
Completado	no aplica	Quadrivalent Intradermal…Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry	abr 2019 (real)
Completado	Fase 1	sotagliflozinDiabetes tipo 2 · Voluntarios sanos	abr 2019 (real)
Completado	Fase 2	SotagliflozinDiabetes	abr 2019 (real)
Completado	Fase 3	ALIROCUMAB SAR236553Hipercolesterolemia	abr 2019 (real)
Completado	Fase 4	cabazitaxel XRP6258 · CARDCabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent	mar 2019 (real)
Completado	Fase 3	CYD Dengue VaccineImmunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®	mar 2019 (real)
Completado	Fase 2	SAR440340Asma	mar 2019 (real)
Completado	Fase 3	Quadrivalent Influenza Vaccine · GQM10Gripe	mar 2019 (real)
Completado	Fase 3	Hexaxim®: DTaP-IPV-HB-PRP-T…DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants	feb 2019 (real)
Completado	Fase 1/2	TesevatinibA Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease	feb 2019 (real)
Completado	Fase 4	INSULIN GLARGINE · TOP1Phase 4 Study to Evaluate Treatment Optimization With Once-daily Insulin Glargine 300 U/mL	feb 2019 (real)
Completado	Fase 3	Hylan G-F 20 · C-SOUNDArtrosis	ene 2019 (real)
Completado	Fase 3	Docetaxel · PRODIGYCancer gastrico	ene 2019 (real)
Completado	Fase 3	HDCV · VAJ00001Imovax® Rabies and VERORAB® Immunogenicity and Safety After One Week 2-sites Intradermal or 1-site Intramuscular Pre-Exposure Prophylaxis Regimens, Followed by a Simulated Post-Exposure Prophylaxis Regimen at One Year	ene 2019 (real)
Completado	Fase 2	SAR156597Esclerosis sistemica	ene 2019 (real)
Interrumpido	Fase 3	Insulin glargine · LixiLan-DDiabetes tipo 2	ene 2019 (real)
Completado	Fase 1	SAR425899Diabetes tipo 2	dic 2018 (real)
Completado	Fase 1	SAR247799Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus	dic 2018 (real)
Completado	Fase 1/2	Isatuximab SAR650984Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies	dic 2018 (real)
Completado	Fase 3	Isatuximab · ICARIA-MMMultinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients	nov 2018 (real)
Interrumpido	Fase 4	Insulin glargineDiabetes tipo 1	nov 2018 (real)
Completado	Fase 2	GZEvaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease	nov 2018 (real)
Completado	Fase 3	PVRVImmunogenicity and Safety of Verorab® in a "One-week" Intradermal Post-exposure Prophylaxis Regimen	nov 2018 (real)
Completado	Fase 1/2	AdvateHemofilia A	nov 2018 (real)
Completado	Fase 3	Insulin glargine · LIXILAN JP-LDiabetes tipo 2	oct 2018 (real)
Completado	Fase 3	MenACYW conjugate vaccineImmunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine in Children	sep 2018 (real)
Completado	Fase 3	ambroxol BIH1526 · DELICIOUSEfficacy and Safety Study of New Ambroxol Hardboiled Lozenges in Acute Pharyngitis	sep 2018 (real)
Completado	Fase 4	SHINEDiabetes tipo 1	ago 2018 (real)
Completado	Fase 3	Alirocumab SAR236553Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy	ago 2018 (real)
Completado	Fase 3	Alirocumab · ODYSSEY EASTHipercolesterolemia	ago 2018 (real)
Completado	Fase 2	ALX-0061Artritis reumatoide	ago 2018 (real)
Completado	Fase 4	Alirocumab SAR236553 · ODYSSEY J-IVUSEvaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia	jul 2018 (real)
Interrumpido	Fase 2	SAR407899A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI	jul 2018 (real)
Completado	Fase 3	MenACYW conjugate vaccineImmunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers	jul 2018 (real)
Completado	Fase 3	Insulin aspart · GEMELLI1Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine	jul 2018 (real)
Completado	no aplica	Observational Study Describing the Immune Profile Induced By Pertussis Vaccines	jul 2018 (real)
Interrumpido	Fase 3	C. difficile Toxoid VaccineStudy of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection	jun 2018 (real)
Completado	Fase 3	Insulin glargine · EDITION JUNIORDiabetes tipo 1	may 2018 (real)
Completado	Fase 3	Insulin glargine · LixiLan-GDiabetes tipo 2	may 2018 (real)
Completado	Fase 2	ALX-0171 3.0 mg · RespireDose Ranging Study of ALX-0171 in Infants Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection	may 2018 (real)
Completado	Fase 4	SP Shz TIVImmunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 Years	may 2018 (real)
Completado	Fase 1	GZ402668A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis	may 2018 (real)
Interrumpido	Fase 2	Cabazitaxel XRP6258 · PRIMCABCabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide	may 2018 (real)
Completado	Fase 3	Insulin glargine · LIXILAN JP-O1Diabetes tipo 2	may 2018 (real)
Completado	Fase 4	INSULIN GLARGINEDiabetes tipo 2	abr 2018 (real)
Completado	Fase 4	IrbesartanDiabetes tipo 2	abr 2018 (real)
Completado	Fase 3	Multi-dose Quadrivalent…Gripe	mar 2018 (real)
Completado	Fase 1	EliglustatA Study to Evaluate Pharmacokinetic Parameters of Eliglustat in Healthy Volunteers Who Are CYP2D6 Extensive or Poor Metabolizers	mar 2018 (real)
Completado	Fase 1	SAR341402Diabetes tipo 1	mar 2018 (real)
Completado	Fase 3	Insulin glargine · LIXILAN JP-O2Diabetes tipo 2	mar 2018 (real)
Completado	Fase 1	SotagliflozinDiabetes · Voluntarios sanos	mar 2018 (real)
Completado	Fase 1	SAR405838Phase 1 Safety Testing of SAR405838	mar 2018 (real)
Completado	Fase 4	Insulin glargineDiabetes tipo 2	mar 2018 (real)
Completado	Fase 1	SotagliflozinDiabetes tipo 2	mar 2018 (real)
Completado	Fase 3	DOCETAXELCancer de cabeza y cuello	ene 2018 (real)
Completado	Fase 3	AlirocumabODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab	ene 2018 (real)
Completado	Fase 2	Dupilumab SAR231893 · EXPEDITIONAsma	ene 2018 (real)
Completado	Fase 2	ALX-0061A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus	ene 2018 (real)
Completado	Fase 4	INSULIN GLARGINE · EASEDiabetes tipo 2	dic 2017 (real)
Completado	no aplica	RG012-01ATHENA: Natural History of Disease Study in Alport Syndrome Patients	dic 2017 (real)
Completado	Fase 1	sotagliflozinDiabetes tipo 1 · Diabetes tipo 2	dic 2017 (real)
Completado	Fase 1/2	QIV-HD by IMGripe	nov 2017 (real)
Completado	Fase 1	alirocumab SAR236553Hipercolesterolemia	nov 2017 (real)
Completado	Fase 4	INSULIN GLARGINE · NEWLANDiabetes tipo 2	nov 2017 (real)
Completado	Fase 4	Fluzone Quadrivalent vaccineSafety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines	nov 2017 (real)
Completado	Fase 3	Meningococcal PolysaccharideImmunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers	oct 2017 (real)
Completado	Fase 4	insulin glargine · REGAIN CONTROLDiabetes tipo 2	oct 2017 (real)
Completado	Fase 1	Caplacizumab Dose 1 ivVoluntarios sanos	oct 2017 (real)
Completado	Fase 4	insulin glargine · Reach-ControlDiabetes tipo 2	oct 2017 (real)
Completado	Fase 3	Meningococcal PolysaccharideStudy of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years	oct 2017 (real)
Completado	Fase 3	Dupilumab · VENTUREAsma	sep 2017 (real)
Completado	Fase 1	SotagliflozinDiabetes tipo 2	ago 2017 (real)
Completado	Fase 4	Insulin glargine · BRIGHTDiabetes tipo 2	ago 2017 (real)
Completado	Fase 4	Lixisenatide · LixiRamDiabetes tipo 2	ago 2017 (real)
Completado	Fase 3	DupilumabAsma	jul 2017 (real)
Completado	Fase 1	ALN-AT3SCA Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients	jul 2017 (real)
Completado	Fase 1	MELATONINStudy to Evaluate Improvements of the Quality of Sleep With NOVANUIT® Triple Action in Healthy Volunteers With Sleep Disorders	jul 2017 (real)
Completado	Fase 3	Alirocumab · ODYSSEY OLEHipercolesterolemia	jun 2017 (real)
Completado	Fase 4	HOE901-U300Diabetes tipo 1	jun 2017 (real)
Completado	Fase 2	SAR156597 · ESTAIRFibrosis pulmonar idiopatica	may 2017 (real)
Completado	Fase 1	SotagliflozinDiabetes	may 2017 (real)
Completado	Fase 1/2	plerixaforA Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone	may 2017 (real)
Completado	Fase 1	Z0063Scintigraphy Study to Compare the Antireflux Activity of the Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects	may 2017 (real)
Retirado antes de empezar	Fase 1	SAR113244Lupus eritematoso sistemico	may 2017 (prevista, ya pasada: sin actualizar en el registro)
Completado	Fase 1	Z0063PH Metry Study to Compare the Antacid Activity of Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects	abr 2017 (real)
Completado	Fase 1	SotagliflozinDiabetes	abr 2017 (real)
Completado	Fase 3	AlirocumabEfficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)	abr 2017 (real)
Retirado antes de empezar	Fase 2	Sargramostim GZ402664Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease	mar 2017 (real)
Completado	Fase 4	AlirocumabEfficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)	mar 2017 (real)
Completado	Fase 4	Fluzone Quadrivalent vaccineGripe	mar 2017 (real)
Retirado antes de empezar	Fase 2	sargramostim GZ402664Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute Myelogenous Leukemia	feb 2017 (real)
Completado	Fase 3	Meningococcal PolysaccharideImmune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine	feb 2017 (real)
Completado	Fase 1/2	Tetanus ToxoidStudy of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects	feb 2017 (real)
Completado	Fase 3	AFLIBERCEPT AVE0005Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen	ene 2017 (real)
Completado	Fase 3	Quadrivalent Inactivated…Gripe	ene 2017 (real)
Completado	Fase 3	Hexaxim®Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth	ene 2017 (real)
Completado	Fase 3	Meningococcal PolysaccharideImmunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine	dic 2016 (real)
Completado	Fase 2	MeningococcalSafety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam	dic 2016 (real)
Completado	Fase 1	eliglustatA Study of the Effects of Hepatic Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate	dic 2016 (real)
Completado	Fase 2	CYD Dengue VaccineStudy of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule	nov 2016 (real)
Retirado antes de empezar	Fase 1	SAR438544Diabetes tipo 1	nov 2016 (prevista, ya pasada: sin actualizar en el registro)
Completado	Fase 3	SarilumabArtritis reumatoide	nov 2016 (real)
Completado	Fase 3	Insulin glargine · AUTOMATIXDiabetes tipo 2	nov 2016 (real)
Completado	Fase 3	Sarilumab SAR153191Artritis reumatoide	oct 2016 (real)
Completado	Fase 2	SAR3419 · STARLYTESAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients	sep 2016 (real)
Completado	Fase 2	PlerixaforMieloma multiple	sep 2016 (real)
Interrumpido	Fase 1	IohexolA Study of Renal Function in Treatment-naïve, Young Male Patients With Fabry Disease	sep 2016 (real)
Retirado antes de empezar	Fase 2	Capecitabine · Drop and GoCapecitabine Plus Aflibercept as Maintenance Therapy Following Capecitabine Plus Oxaliplatin Plus Aflibercept in Patients With Metastatic Colorectal Cancer	ago 2016 (prevista, ya pasada: sin actualizar en el registro)
Completado	no aplica	MeningococcalObservational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian Federation	jul 2016 (real)
Completado	Fase 1	GZ389988Artrosis	jul 2016 (real)
Completado	Fase 3	Euvax B®: Hepatitis B vaccineHepatitis B	jun 2016 (real)
Completado	Fase 1	Insulin glargineDiabetes tipo 2	jun 2016 (real)
Completado	Fase 3	Phosphatidylcholine · EPLIDEssentiale® Paste in Patients With Gastrointestinal Symptoms in Acute or Chronic Liver Diseases	jun 2016 (real)
Completado	no aplica	Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving PlerixaforLinfoma · Mieloma multiple	jun 2016 (real)
Completado	Fase 3	DTaP-IPVDTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants	may 2016 (real)
Completado	Fase 3	Insulin Glargine · SENIORDiabetes tipo 2	may 2016 (real)
Completado	no aplica	Association of Host Genetics With Vaccine Efficacy and Study of Immune Correlates of Risk From a Tetravalent Dengue Vaccine	abr 2016 (real)
Completado	Fase 3	Meningococcal Diphtheria Toxoid…Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation	abr 2016 (real)
Completado	Fase 2	High-dose quadrivalent…Gripe	abr 2016 (real)
Completado	Fase 1	SAR125844 · SARMETStudy of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors	abr 2016 (real)
Completado	Fase 3	DTaP-IPV-Hep B-PRP~T combined…DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants	abr 2016 (real)
Completado	Fase 3	GEMIGLIPTIN LS15-0444Diabetes tipo 2	abr 2016 (real)
Completado	Fase 3	AlirocumabHipercolesterolemia	abr 2016 (real)
Completado	Fase 1	Latanoprost28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension	abr 2016 (real)
Completado	Fase 1	SAR342434Diabetes tipo 1	abr 2016 (real)
Interrumpido	Fase 2	Vatelizumab · EMPIREEsclerosis multiple remitente-recurrente	abr 2016 (real)
Completado	Fase 3	Quadrivalent influenza vaccineGripe	abr 2016 (real)
Completado	Fase 1	GZ402668A First-in-human, Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis	mar 2016 (real)
Completado	Fase 4	ADACEL™:Adsorbed DiphtheriaPost Marketing Surveillance for ADACEL™ in South Korea	mar 2016 (real)
Completado	Fase 2	plerixafor GZ316455Linfoma	mar 2016 (real)
Completado	Fase 1	sarilumab SAR153191Artritis reumatoide	mar 2016 (real)
Completado	Fase 1	Acyclovir · SCALAA Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis	mar 2016 (real)
Completado	Fase 3	Live attenuated Japanese…Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects	mar 2016 (real)
Completado	Fase 1	SAR438544Diabetes tipo 1	feb 2016 (real)
Completado	Fase 4	CABAZITAXEL XRP6258 · PEGAZUSCancer de prostata	feb 2016 (real)
Completado	Fase 3	INSULIN GLARGINE · TITRATIONDiabetes tipo 2	feb 2016 (real)
Completado	Fase 3	alemtuzumabEsclerosis multiple remitente-recurrente	feb 2016 (real)
Completado	Fase 3	SAR342434 · SORELLA2Diabetes tipo 2	feb 2016 (real)
Completado	Fase 3	SarilumabArtritis reumatoide	ene 2016 (real)
Completado	Fase 2	SAR125844A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET Amplification	ene 2016 (real)
Completado	Fase 4	TOFOGLIFLOZIN CSG452Diabetes tipo 2	ene 2016 (real)
Completado	Fase 1	SAR425899Diabetes tipo 2	ene 2016 (real)
Completado	Fase 4	Bacillus clausii · cadiLAcEvaluation Of Bacillus Clausii In Treatment Of Acute Diarrhea In Latin American Children	ene 2016 (real)
Completado	Fase 4	Tetanus ToxoidSafety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose	dic 2015 (real)
Completado	Sin fase asignada	DTaP-IPV-HB-PRP~T and…Hepatitis B	dic 2015 (real)
Completado	Fase 4	Fluzone Quadrivalent vaccineGripe	dic 2015 (real)
Completado	Fase 3	TeriflunomideEsclerosis multiple	dic 2015 (real)
Completado	Fase 3	SAR342434 · SORELLA1Diabetes tipo 1	dic 2015 (real)
Completado	Fase 4	LIXISENATIDE AVE0010Diabetes tipo 2	nov 2015 (real)
Completado	Fase 4	TETRAXIM™: Combined adsorbed…Regulatory Post-Marketing Surveillance Study for TETRAXIM™	nov 2015 (real)
Completado	no aplica	Regulatory Post-Marketing Surveillance Study for Hepatitis A Vaccine (AVAXIM 160U)Hepatitis A	nov 2015 (real)
Completado	Fase 4	Teriflunomide · TERI-PROEsclerosis multiple	nov 2015 (real)
Completado	Fase 2	Meningococcal PolysaccharideImmunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents	oct 2015 (real)
Completado	Fase 3	Eliglustat tartrateA Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE)	oct 2015 (real)
Completado	Fase 3	Cabazitaxel · FIRSTANACancer de prostata	sep 2015 (real)
Completado	Fase 3	Vandetanib · VERIFYEvaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer	ago 2015 (real)
Completado	Fase 2	DOCETAXEL · TAXYNERGYEarly Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)	ago 2015 (real)
Completado	Fase 3	Cabazitaxel · PROSELICACancer de prostata	ago 2015 (real)
Interrumpido	Fase 2	LIXISENATIDE AVE0010Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients	ago 2015 (real)
Completado	Fase 2	AfliberceptA Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan	ago 2015 (real)
Completado	Sin fase asignada	BGStar · SELF CAREDiabetes	jul 2015 (real)
Completado	Fase 3	Insulin glargine · LixiLan-LDiabetes tipo 2	jul 2015 (real)
Completado	Fase 2	plerixafor GZ316455Mieloma multiple	jul 2015 (real)
Completado	Fase 3	lixisenatide AVE0010Diabetes tipo 2	jul 2015 (real)
Completado	Fase 2	Sarilumab · SARILNIUSATURNPhase II Study to Analyze Sarilumab in Non-Infectious Uveitis	jul 2015 (real)
Completado	Fase 3	FEX60A Study Assessing the Safety and Effectiveness of FEX60/PE10 Fixed Combination Tablet in Patients With Allergic Rhinitis	jul 2015 (real)
Completado	Fase 3	Agalsidase beta · FIELDA Study of Two Fabrazyme (Agalsidase Beta) Dosing Regimens in Treatment-naïve, Male Pediatric Patients Without Severe Symptoms	jun 2015 (real)
Completado	Fase 1/2	bsi-201 plus temozolomideGlioblastoma	jun 2015 (real)
Completado	no aplica	Menactra®: Meningococcal…Post-licensure Safety Surveillance Study of Menactra Vaccine When Administered As a 2-dose Schedule to Children	jun 2015 (real)
Completado	Fase 3	AFLIBERCEPT · AFEQTColorectal Cancer Metastatic	jun 2015 (real)
Completado	Sin fase asignada	Synvisc-OneA Study of the Safety and Effectiveness of Synvisc-One® (Hylan G-F 20) in Patients With Primary Osteoarthritis of the Hip	jun 2015 (real)
Completado	Fase 1	alirocumabHipercolesterolemia	may 2015 (real)
Completado	Fase 1	eliglustatTaste Evaluation of Different Liquid Formulations With Eliglustat	may 2015 (real)
Completado	Fase 4	INSULIN GLARGINE · TEDDiabetes tipo 2	abr 2015 (real)
Completado	Fase 4	IMOJEV®: Live attenuated…Post-licensure Safety Study of IMOJEV® in Thailand	abr 2015 (real)
Completado	Fase 4	INSULIN GLARGINE · SeLanDiabetes tipo 2	abr 2015 (real)
Completado	Fase 1	DupilumabVoluntarios sanos	mar 2015 (real)
Completado	Fase 3	SarilumabArtritis reumatoide	mar 2015 (real)
Completado	Fase 3	lixisenatide AVE0010Diabetes tipo 2	mar 2015 (real)
Completado	Fase 3	HBVAXPRO 5µgStudy of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA	feb 2015 (real)
Completado	Fase 3	Lixisenatide · ELIXAEvaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)	feb 2015 (real)
Completado	Fase 3	Sarilumab · SARIL-RA-EASYTo Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis	feb 2015 (real)
Completado	Fase 4	Shanchol™: Oral Cholera Vaccine…A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines	feb 2015 (real)
Completado	Fase 1	SAR260301A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer	feb 2015 (real)
Completado	Fase 1	SAR228810Enfermedad de Alzheimer	feb 2015 (real)
Completado	Fase 1	SAR245408A Study of the Safety and Pharmacokinetics of SAR245408 Tablets in Patients With Solid Tumors or Lymphoma	feb 2015 (real)
Completado	Fase 3	AlirocumabHipercolesterolemia	ene 2015 (real)
Completado	Fase 3	teriflunomide HMR1726 · TERI-DYNAMICEsclerosis multiple	ene 2015 (real)
Completado	Fase 2	teriflunomideEsclerosis multiple	ene 2015 (real)
Completado	no aplica	Pentacel®Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines	dic 2014 (real)
Completado	Fase 3	Lixisenatide · GetGoal-Duo-2Diabetes tipo 2	dic 2014 (real)
Completado	Fase 3	CABAZITAXELEarly Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen	dic 2014 (real)
Completado	no aplica	DTaP-IPVSurveillance Program to Determine Product Specific Rates of Invasive Hib Disease	dic 2014 (real)
Completado	Fase 4	Fluzone® Quadrivalent Influenza…Gripe	dic 2014 (real)
Completado	Fase 3	Hexaxim™: DTaP-IPV-Hep B-PRP~T…Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth	dic 2014 (real)
Completado	Fase 3	DoxorubicinCancer de mama	dic 2014 (real)
Interrumpido	Fase 4	alglucosidase alfaA Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients With Infantile-Onset Pompe Disease	dic 2014 (real)
Completado	Fase 4	Shenzhen trivalent influenza…Gripe	dic 2014 (real)
Completado	Fase 4	Fluzone® Quadrivalent vaccineGripe	nov 2014 (real)
Completado	Fase 3	Granulocyte-colony stimulating…Linfoma no Hodgkin	nov 2014 (real)
Completado	Fase 3	LiveStudy of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America	nov 2014 (real)
Completado	Fase 4	Meningococcal polysaccharide…Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age	nov 2014 (real)
Completado	Fase 3	AlirocumabHipercolesterolemia	oct 2014 (real)
Completado	Fase 3	Aflibercept · AFLAMEA Study of Aflibercept Versus Placebo With FOLFIRI in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin Chemotherapy	oct 2014 (real)
Completado	Fase 2	CYD Dengue vaccineStudy of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore	oct 2014 (real)
Completado	Fase 1	SAR245409A Study of the Safety and Pharmacokinetics of SAR245409 Tablets in Patients With Solid Tumors or Lymphoma	oct 2014 (real)
Completado	Fase 3	sarilumab SAR153191Artritis reumatoide	oct 2014 (real)
Completado	Fase 1	Eliglustat · AcronymA Study to Evaluate Pharmacokinetic Parameters and Safety of Eliglustat Absorption Through the Mouth	sep 2014 (real)
Completado	Fase 4	Avaxim 80U Pediatric:…Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and Adolescents	sep 2014 (real)
Completado	Fase 4	IMOVAX POLIO®: Inactive…Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in Japan	sep 2014 (real)
Completado	Fase 2	SAR245409Linfoma	sep 2014 (real)
Completado	Fase 3	Tdap: Tetanus toxoidStudy of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years Old	sep 2014 (real)
Completado	no aplica	DTaP-IPVDatabase Surveillance Safety Study of PENTACEL® Vaccine	ago 2014 (real)
Completado	Fase 2	Purified Vero Rabies Vaccine…Purified Vero Rabies Vaccine-Serum Free Compared to Human Diploid Cell Vaccine in a Pre-exposure Prophylaxis Regimen	ago 2014 (real)
Completado	Fase 2	CYD dengue vaccine serotypesStudy of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects	ago 2014 (real)
Completado	Fase 1	ALX-0061Artritis reumatoide	jul 2014 (real)
Completado	Fase 3	Hexavalent vaccineConcomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination	jul 2014 (real)
Completado	Fase 2	Ombrabulin · OPSALINStudy of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel	jul 2014 (real)
Completado	Fase 3	sevelamer carbonate 800mg · TOSCANAAn Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic CKD Patients	jul 2014 (real)
Completado	Fase 1/2	Cabazitaxel XRP6258Cancer de prostata	jul 2014 (real)
Completado	no aplica	Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor	jul 2014 (real)
Completado	Fase 1	AAV2-sFLT01Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)	jul 2014 (real)
Completado	Fase 1	Teriflunomide HMR1726Esclerosis multiple	jul 2014 (real)
Completado	Fase 1	Belumosudil mesylateA Study to Determine the Effect of 500 mg Oral Dose of KD025 in Healthy Male and Post-menopausal Female Subjects	jun 2014 (real)
Interrumpido	Fase 2	SAR339658 · FUSCIAColitis ulcerosa	jun 2014 (real)
Completado	Fase 3	AlirocumabEfficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH)	may 2014 (real)
Completado	Fase 3	AlirocumabHipercolesterolemia	may 2014 (real)
Completado	Fase 1	MM-121A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers	may 2014 (real)
Completado	Fase 1	SAR245409Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia	may 2014 (real)
Completado	Fase 4	300mg vandetanibCancer de tiroides	abr 2014 (real)
Completado	Fase 2	Purified Vero Rabies VaccineComparison of Purified Vero Rabies Vaccine, Serum Free With Human Diploid Cell Vaccine in Pre-exposure Use	abr 2014 (real)
Completado	Fase 3	Quadrivalent Influenza VaccineGripe	abr 2014 (real)
Completado	Fase 2	CabazitaxelCancer de pulmon microcitico	abr 2014 (real)
Completado	Fase 3	Glimepiride+metformin · LEGENDDiabetes tipo 2	abr 2014 (real)
Completado	Fase 3	IMOJEVStudy of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea	mar 2014 (real)
Completado	Fase 1	Belumosudil mesylateA Study to Determine the Effect of Multiple Oral Doses and Regimens of KD025 in Healthy Male and Post-menopausal Female Subjects	mar 2014 (real)
Completado	Fase 1	rifapentineInteraction Study to Assess the Pharmacokinetic Interaction of Oral Administration of Rifapentine on ATRIPLA™ in HIV Patients	mar 2014 (real)
Completado	Fase 2	Caplacizumab · TITANStudy to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)	mar 2014 (real)
Completado	Fase 3	Insulin glargine · Lantus-P-CNDiabetes tipo 1	mar 2014 (real)
Completado	Fase 2	DOCETAXEL · C-CRISPConcurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer	mar 2014 (real)
Completado	Fase 3	LiveStudy of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers	feb 2014 (real)
Completado	Fase 3	Tetanus ToxoidSanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China.	feb 2014 (real)
Retirado antes de empezar	Fase 3	oxaliplatin · SECOXOxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma Patients	feb 2014 (prevista, ya pasada: sin actualizar en el registro)
Completado	Fase 2	AlirocumabHipercolesterolemia	ene 2014 (real)
Completado	Fase 4	CABAZITAXEL · PROSPECTACancer de prostata	ene 2014 (real)
Completado	Fase 1	Recombinant human acid…Tolerability and Safety Study of Recombinant Human Acid Sphingomyelinase in Acid Sphingomyelinase Deficiency Patients	ene 2014 (real)
Completado	Fase 2	CABAZITAXEL · SWITCHContinued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate Cancer	dic 2013 (real)
Completado	Fase 4	Fluzone® QuadrivalentGripe	dic 2013 (real)
Completado	Fase 4	Alglucosidase AlfaExploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa	dic 2013 (real)
Completado	Fase 4	Menactra®: Meningococcal…Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the Philippines	dic 2013 (real)
Completado	Fase 2	LiveStudy of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India	dic 2013 (real)
Completado	Fase 1	ALX-0171ALX-0171 Safety Study in Adults With Hyperresponsive Airways	dic 2013 (real)
Completado	Fase 3	hydroxychloroquineMulticenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion	dic 2013 (real)
Completado	Fase 4	AMISULPRIDE · ESCAPEEsquizofrenia	dic 2013 (real)
Completado	Fase 1/2	Vandetanib 300mgEvaluate the Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid Carcinoma	dic 2013 (real)
Completado	Fase 3	Insulin glargine new formulation · EDITION JP IIDiabetes tipo 2	nov 2013 (real)
Completado	Fase 2	SAR100842Esclerosis sistemica	nov 2013 (real)
Completado	Fase 1	Cabazitaxel XRP6258Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment	nov 2013 (real)
Completado	Fase 3	JE-CV administered in Study…Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers	oct 2013 (real)
Completado	Fase 4	INSULIN GLARGINE · DINAMODiabetes tipo 2	oct 2013 (real)
Completado	Fase 1	OmbrabulinTumor solido avanzado	oct 2013 (real)
Completado	Fase 2/3	Sarilumab · RA-MOBILITYArtritis reumatoide	oct 2013 (real)
Completado	Fase 3	LeucovorinRandomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer	oct 2013 (real)
Completado	Fase 3	Insulin glargine new formulation · EDITION JP IDiabetes tipo 1	oct 2013 (real)
Completado	Fase 4	Artesunate + AmodiaquineArtesunate Plus Amodiaquine in Malaria in Cote d'Ivoire	oct 2013 (real)
Completado	Fase 1	ALX-0171Voluntarios sanos · Infeccion por virus respiratorio sincitial	oct 2013 (real)
Completado	Fase 1/2	SAR156597Fibrosis pulmonar idiopatica	oct 2013 (real)
Completado	Fase 3	HOE901-U300 · EDITION IVDiabetes tipo 1	sep 2013 (real)
Completado	Fase 4	Hylan G-F 20Artrosis	sep 2013 (real)
Completado	Fase 3	LiveStudy of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers	sep 2013 (real)
Completado	Fase 1	insulin glargineDiabetes tipo 1	ago 2013 (real)
Completado	Fase 3	Alirocumab · ODYSSEY MONOHipercolesterolemia	jul 2013 (real)
Completado	Fase 1	SAR342434Diabetes tipo 1	jul 2013 (real)
Completado	Fase 1	alirocumab SAR236553Hipercolesterolemia	jul 2013 (real)
Completado	Fase 2	SAR3419Combination of SAR3419 and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma	jul 2013 (real)
Completado	Fase 3	Influenza Virus Vaccine USP…Gripe	jun 2013 (real)
Completado	Fase 3	ARTESUNATE + AMODIAQUINEEfficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax Malaria	jun 2013 (real)
Interrumpido	Fase 4	Ketoprofen · DROPSEvaluation of Inflammatory Symptoms Reduction With Amoxicillin + Ketoprofen in Acute Pharyngeal Tonsillitis in Pediatric Patients	jun 2013 (real)
Completado	no aplica	36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds	may 2013 (real)
Completado	Fase 3	LixisenatideDiabetes tipo 2	may 2013 (real)
Completado	Fase 3	Diphtheria and Tetanus Toxoids…Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age	may 2013 (real)
Completado	Fase 4	High Dose Trivalent Inactivated…Gripe	may 2013 (real)
Completado	no aplica	Descriptive, Post-marketing, Surveillance Safety Study of Menactra Vaccine	may 2013 (real)
Completado	Fase 4	Injectable inactivated types 1Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine	may 2013 (real)
Completado	Fase 1	IniparibA Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors	may 2013 (real)
Completado	Fase 1	alirocumab SAR236553Hipercolesterolemia	may 2013 (real)
Completado	Fase 2	SAR292833 · AlchemillaDolor neuropatico	may 2013 (real)
Completado	Fase 2	HOE901-U300Diabetes tipo 1	may 2013 (real)
Completado	Fase 3	Otamixaban · TAOEffect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy	may 2013 (real)
Completado	Fase 3	VandetanibStudy to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment	abr 2013 (real)
Completado	Fase 1/2	XL147Cancer de mama	abr 2013 (real)
Completado	Fase 3	OMBRABULINSarcoma	abr 2013 (real)
Completado	Fase 3	Lantus · EDITION IIDiabetes tipo 2	abr 2013 (real)
Completado	Fase 3	gemcitabine · ECLIPSETrial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)	abr 2013 (real)
Completado	Fase 3	DTaP-IPV-Hep B-PRP~T combined…Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants	abr 2013 (real)
Interrumpido	Fase 3	Teriflunomide · TERACLESEfficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta	abr 2013 (real)
Completado	Fase 4	Tetanus ToxoidImmunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents	mar 2013 (real)
Completado	Fase 1	AAV-hAADC-2Enfermedad de Parkinson	mar 2013 (real)
Completado	Fase 4	Alglucosidase AlfaAn Exploratory Study of the Safety and Efficacy of Prophylactic Immunomodulatory Treatment in Myozyme-naive Cross-Reacting Immunologic Material (CRIM[-]) Patients With Infantile-Onset Pompe Disease	mar 2013 (real)
Completado	Fase 2	XL147Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Carcinoma	mar 2013 (real)
Completado	Fase 3	Glutamine · GLUTOXOral Glutamine in the Prevention of Oxaliplatin-induced Neurotoxicity	mar 2013 (real)
Completado	Fase 1	cabazitaxelA Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid Cancer	mar 2013 (real)
Completado	Fase 1	Genz-682452Voluntarios sanos	feb 2013 (real)
Completado	Fase 2	SAR113945Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part II	feb 2013 (real)
Completado	Fase 4	Granulocyte-colony stimulating…Linfoma no Hodgkin	feb 2013 (real)
Completado	Fase 1	IniparibSafety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors	feb 2013 (real)
Completado	Fase 3	Glimepiride and Metformin…Diabetes tipo 2	feb 2013 (real)
Completado	Fase 3	IrbesartanHipertension	ene 2013 (real)
Completado	Fase 1	Genz-682452Voluntarios sanos	ene 2013 (real)
Completado	Fase 4	INSULIN GLARGINE · SUBSTITUTEDiabetes tipo 1	ene 2013 (real)
Completado	Fase 2	SAR110894Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil	ene 2013 (real)
Completado	Fase 3	MeningococcalSafety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South Korea	ene 2013 (real)
Completado	Fase 1	SAR341402Diabetes tipo 1	dic 2012 (real)
Completado	Fase 2	Insulin glargineDiabetes tipo 2	dic 2012 (real)
Completado	Fase 4	INSULIN GLARGINE · LanScapeDiabetes tipo 2	dic 2012 (real)
Completado	Fase 4	Fluzone®: Influenza Virus…Gripe	dic 2012 (real)
Completado	Fase 3	Teriflunomide · TOPICEsclerosis multiple	dic 2012 (real)
Completado	Fase 4	DiphtheriaAntibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE	dic 2012 (real)
Interrumpido	Fase 2	SAR279356Pharmacokinetics, Pharmacodynamics and Safety Evaluation of SAR279356 in Intensive Care Unit Mechanically Ventilated Patients	dic 2012 (real)
Completado	Fase 4	INSULIN GLARGINE HOE 901 · GAUDIDiabetes tipo 2	dic 2012 (real)
Completado	Fase 1/2	XL147Cancer de mama	dic 2012 (real)
Completado	Fase 2	BSI-201Cancer de ovario	dic 2012 (real)
Completado	Fase 1/2	Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents	nov 2012 (real)
Completado	no aplica	PlerixaforRegistry of Patients Treated With Plerixafor (Mozobil®) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation	nov 2012 (real)
Completado	Fase 3	LiveStudy of a Tetravalent Dengue Vaccine in Healthy Adults in Australia	nov 2012 (real)
Completado	Fase 3	Insulin human · Insuman-C25-CNDiabetes tipo 2	nov 2012 (real)
Completado	Fase 4	Influenza Virus Vaccine:…Gripe	nov 2012 (real)
Completado	Fase 4	Insulin Glarginediabetes mellitus tipo 2	oct 2012 (real)
Completado	Fase 1	SAR231893Voluntarios sanos	oct 2012 (real)
Completado	Fase 2	DupilumabAsma	oct 2012 (real)
Completado	Fase 4	Insulin glargine · EAGLEDiabetes tipo 2	oct 2012 (real)
Completado	Fase 2	gemcitabine plus carboplatin…Cancer de mama triple negativo	oct 2012 (real)
Completado	Fase 2	LiveStudy of CYD Dengue Vaccine in Healthy Children and Adolescents in South America	oct 2012 (real)
Completado	Fase 2	INIPARIB + irinotecanA Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis	oct 2012 (real)
Completado	Fase 4	INSULIN GLULISINEDiabetes tipo 1	oct 2012 (real)
Completado	Fase 3	LiveStudy of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia	sep 2012 (real)
Completado	Fase 3	Meningococcal polysaccharide…Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects	sep 2012 (real)
Completado	Fase 1	VandetanibStudy in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib	sep 2012 (real)
Completado	no aplica	Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children	sep 2012 (real)
Completado	Fase 1/2	LaronidaseImmune Tolerance Study With Aldurazyme® (Laronidase)	sep 2012 (real)
Completado	Fase 1	SAR113945Safety, Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee Osteoarthritis	sep 2012 (real)
Completado	Fase 1	XL765Cancer	sep 2012 (real)
Completado	Fase 3	Typhoid Vi polysaccharideStudy of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects	sep 2012 (real)
Completado	Fase 1/2	ALX-0061Artritis reumatoide	sep 2012 (real)
Completado	Fase 3	SENNA+CASSIAEvaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment.	ago 2012 (real)
Completado	Fase 1	SAR113945Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part I	ago 2012 (real)
Completado	Fase 3	Docetaxel · TFINETax First-line Chemotherapy With Different Doses and Then Maintenance Therapy	ago 2012 (real)
Completado	Fase 4	MeningococcalStudy of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in Children	ago 2012 (real)
Completado	no aplica	ThyrogenCancer de tiroides	ago 2012 (real)
Completado	Fase 4	DTacP IPVSafety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China	jul 2012 (real)
Interrumpido	Fase 2	Semuloparin sodiumStudy of AVE5026 at Weight-adjusted Doses in Children With a Central Venous Line	jul 2012 (real)
Completado	Fase 4	Insulin Glargine · LANCELOTDiabetes tipo 2	jul 2012 (real)
Completado	Fase 3	MeningococcalStudy of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations	jul 2012 (real)
Completado	Fase 4	LENOGRASTIM · Grano-TaxA Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen	jul 2012 (real)
Completado	Fase 1	Midazolam · VandetanibVoluntarios sanos	jul 2012 (real)
Completado	Fase 4	INSULIN GLARGINE · CHANGINGDiabetes tipo 2	jul 2012 (real)
Interrumpido	Fase 4	Insulin glulisine · BASAAL PLUSDiabetes tipo 2	jul 2012 (real)
Completado	Fase 1	SAR3419SAR3419 Administered Weekly in Patients With Relapsed/Refractory CD19-positive B-cell Non-Hodgkin's Lymphoma	jun 2012 (real)
Completado	Fase 2	MeningococcalStudy of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine	jun 2012 (real)
Completado	Fase 1	XL765Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection	jun 2012 (real)
Completado	Fase 3	DocetaxelTaxotere Prostate Cancer New Indication Registration Trial in China	jun 2012 (real)
Completado	Fase 1	EliglustatVoluntarios sanos	jun 2012 (real)
Completado	Fase 1	SAR245408Tumor solido	jun 2012 (real)
Completado	Fase 1	Metformin 1000 mg · VandetanibVoluntarios sanos	jun 2012 (real)
Completado	Fase 4	Insulin Glargine · Pen PreferenceDiabetes tipo 2	may 2012 (real)
Completado	Fase 4	Clopidogrel · COMPRESSCOMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke	may 2012 (real)
Completado	Fase 4	INSULIN GLARGINE · B to BDiabetes tipo 2	may 2012 (real)
Completado	Fase 1	ALX-0171Infeccion por virus respiratorio sincitial	may 2012 (real)
Completado	Fase 1	XL147Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors	may 2012 (real)
Completado	Fase 3	DiphtheriaSafety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older	may 2012 (real)
Retirado antes de empezar	Fase 2	OXALIPLATINColorectal Cancer RECHALLENGE	may 2012 (prevista, ya pasada: sin actualizar en el registro)
Completado	Fase 1	Insulin glargine HOE901Diabetes tipo 1	abr 2012 (real)
Completado	Fase 3	Aflibercept · VENICEAflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer	abr 2012 (real)
Completado	Fase 1	PlerixaforLeucemia mieloide aguda	mar 2012 (real)
Completado	Fase 2	ombrabulin · DISRUPTCancer de pulmon no microcitico	mar 2012 (real)
Completado	Fase 2	Docetaxel · NEOTAXDocetaxel in Locally Advanced Gastric Adenocarcinoma	mar 2012 (real)
Completado	Fase 4	GLIMEPIRIDE + METFORMIN · DIAGRAMDiabetes tipo 2	mar 2012 (real)
Completado	Fase 4	INSULIN GLARGINE · GALAPAGOSDiabetes tipo 2	mar 2012 (real)
Completado	Fase 3	Purified inactivated rabies…Study of the Purified Vero Rabies Vaccine - Serum Free in Comparison With the Reference Purified Vero Rabies Vaccine	mar 2012 (real)
Interrumpido	Fase 4	Dronedarone · HESTIAEffects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers	feb 2012 (real)
Completado	Fase 2	ATN-103Artritis reumatoide	feb 2012 (real)
Completado	Fase 2	BSI-201Cancer de ovario	feb 2012 (real)
Completado	Fase 1	plerixaforVoluntarios sanos	feb 2012 (real)
Completado	Fase 4	Influenza Virus Vaccine:…Gripe	feb 2012 (real)
Completado	Fase 1	SAR245408Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid Tumors	feb 2012 (real)
Completado	Fase 1	XL765A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas	feb 2012 (real)
Interrumpido	Fase 4	Dronedarone · ODYSSEUSFibrilacion auricular	ene 2012 (real)
Interrumpido	Fase 1	ALX-0651Voluntarios sanos	ene 2012 (real)
Completado	Fase 1	SAR3419Multi-dose-escalation Safety and Pharmacokinetic Study of SAR3419 as Single Agent in Relapsed/Refractory B-cell Non Hodgkin's Lymphoma	ene 2012 (real)
Completado	Fase 1	SAR103168Leucemia mieloide aguda	ene 2012 (real)
Completado	Fase 3	Inactive Poliovirus VaccineStudy of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan	ene 2012 (real)
Completado	Fase 1	AlirocumabHipercolesterolemia	ene 2012 (real)
Interrumpido	Fase 2	SAR97276AAnti-parasitic Activity and Safety Assessment of SAR97276A in Children With Uncomplicated Malaria	ene 2012 (real)
Completado	no aplica	Lapas IIDiabetes tipo 2	ene 2012 (real)
Completado	Fase 2	teriflunomide · TERIVAEsclerosis multiple	ene 2012 (real)
Completado	Fase 1	OMBRABULINDose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid Tumors	dic 2011 (real)
Interrumpido	Fase 2	Sarilumab · SUSTAINExtension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis	dic 2011 (real)
Completado	no aplica	Study of Febrile Illness for Dengue-Endemic Areas in Latin America	dic 2011 (real)
Completado	Fase 4	DRONEDARONE · ARTEMIS LoadOptimal Timing of Dronedarone Initiation After Conversion in Patients With Persistent Atrial Fibrillation	dic 2011 (real)
Completado	Fase 4	IMOVAX Polio™: Inactivated…A Safety Study of IMOVAX Polio Vaccine in Selected Cities in China	dic 2011 (real)
Completado	Fase 3	Lixisenatide · GetGoal-M-AsiaDiabetes tipo 2	dic 2011 (real)
Completado	Fase 3	SENNA+CASSIAEfficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC).	dic 2011 (real)
Completado	Fase 3	insulin glargine · ORIGINThe ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)	dic 2011 (real)
Completado	Fase 3	Licensed 2010-2011 Trivalent…Gripe	dic 2011 (real)
Completado	Fase 4	Adacel®: Tetanus ToxoidStudy of Adacel® Vaccine Administered to Persons 10 Years of Age	nov 2011 (real)
Completado	Fase 3	PENTAXIM™: DTacP IPVStudy of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants.	nov 2011 (real)
Completado	Fase 1	eliglustatVoluntarios sanos	nov 2011 (real)
Completado	no aplica	granulocyte colony-stimulating…Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610).	nov 2011 (real)
Completado	Fase 1	EliglustatVoluntarios sanos	nov 2011 (real)
Completado	Fase 1	PF-05230905 · FIHVoluntarios sanos	nov 2011 (real)
Completado	Fase 1	alirocumab SAR236553Hipercolesterolemia	nov 2011 (real)
Completado	Fase 3	DTaP-IPV-Hep B-PRP-T VaccineA Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants	oct 2011 (real)
Completado	Fase 2	Doxorubicin and cyclophosphamideCancer de mama	oct 2011 (real)
Completado	no aplica	RECORDAF-APThe RECORD Asia-Pacific Atrial Fibrillation Registry	oct 2011 (real)
Completado	Sin fase asignada	Paxman Cooling MachineSTART: Swiss Taxotere Alopecia Prevention Trial	oct 2011 (real)
Completado	Fase 4	TAA-AQStudy of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR)	oct 2011 (real)
Completado	Fase 1	AfliberceptA Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid Tumors	sep 2011 (real)
Completado	Fase 2	CYD Dengue VaccineImmunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America	sep 2011 (real)
Completado	Fase 3	Concomitant administrationSafety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old	sep 2011 (real)
Completado	Fase 3	Doxorubicine + docetaxel…Cancer de mama	sep 2011 (real)
Completado	no aplica	A Long-Term Study of Healthy Adults Vaccinated With One Dose of Smallpox Vaccine (LISTER Strain)Viruela	sep 2011 (real)
Completado	Fase 4	Dronedarone · AFRODITEEffect of Addition of Dronedarone to Standard Rate Control Therapy on Ventricular Rate During Persistent Atrial Fibrillation (AFRODITE)	sep 2011 (real)
Completado	Fase 4	Synvisc-One · OASISArtrosis	sep 2011 (real)
Completado	Fase 3	Japanese encephalitis chimeric…A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers	sep 2011 (real)
Completado	Fase 1	SAR153191Artritis reumatoide	sep 2011 (real)
Completado	Fase 3	Interferon β-1a · TENEREEsclerosis multiple	sep 2011 (real)
Interrumpido	Fase 3	Dronedarone · PALLASPermanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy	sep 2011 (real)
Completado	Fase 3	DTaPA Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants	sep 2011 (real)
Completado	Fase 3	Insulin GlargineDiabetes tipo 2	sep 2011 (real)
Completado	Fase 2	AlirocumabHipercolesterolemia	sep 2011 (real)
Completado	Fase 1	alirocumab SAR236553Hipercolesterolemia	sep 2011 (real)
Completado	Fase 3	Lixisenatide · GetGoal-Duo1Diabetes tipo 2	ago 2011 (real)
Completado	Fase 2	Bevacizumab · TEACOCancer de ovario	ago 2011 (real)
Completado	Fase 2	AlemtuzumabSubcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia	ago 2011 (real)
Completado	Fase 1	ombrabulinTumor solido	ago 2011 (real)
Completado	Fase 1	alemtuzumabA Safety Confirmatory Study of Alemtuzumab in Japanese Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia	ago 2011 (real)
Completado	Fase 2/3	fexofenadineDermatitis atopica	jul 2011 (real)
Completado	Fase 1	OTAMIXABANInsuficiencia renal	jul 2011 (real)
Completado	Fase 4	Insulin Glargine · EASIEDiabetes tipo 2	jul 2011 (real)
Completado	Fase 2	0.9% Normal SalineStudy of a Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile Infection	jul 2011 (real)
Completado	Fase 2	MRrhTSHStudy to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular Goiter	jul 2011 (real)
Completado	no aplica	plerixaforLong-Term Follow-up Study for Multiple Myeloma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3102 Study (NCT00103662).	jul 2011 (real)
Completado	no aplica	Tetanus ToxoidDescriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine	jul 2011 (real)
Completado	Fase 1	Study Comparing The Tolerability Of Three Excipient Formulations Administered Subcutaneously To Healthy SubjectsVoluntarios sanos	jun 2011 (real)
Completado	Fase 2	Sarilumab · ALIGNDose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis	jun 2011 (real)
Completado	Fase 4	IMOVAX Polio™-Inactivated types…A Study of the Safety of IMOVAX Polio™ in China	jun 2011 (real)
Completado	Fase 2	ClofarabineA Dose Confirmation Study of Oral Clofarabine for Adult Patients Previously Treated for Myelodysplastic Syndromes (MDS)	may 2011 (real)
Completado	Fase 1	Insulin glargine HOE901Diabetes tipo 1	may 2011 (real)
Interrumpido	Fase 3	Trivalent inactivated influenza…Gripe	may 2011 (real)
Completado	Fase 1	ClofarabineLeucemia linfoblastica aguda	may 2011 (real)
Completado	Fase 1	alirocumab SAR236553Hipercolesterolemia	may 2011 (real)
Completado	Fase 1	ombrabulinDose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Cisplatin in Patients With Solid Tumors	may 2011 (real)
Completado	Fase 3	clopidogrelSafety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease	may 2011 (real)
Completado	Fase 1	clofarabineLeucemia mieloide aguda	abr 2011 (real)
Completado	Fase 2	aflibercept · AFFIRMStudy of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer	abr 2011 (real)
Completado	Fase 2	ALX-0081Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients	abr 2011 (real)
Completado	Fase 1	Cabazitaxel · QT-CabEffect of Cabazitaxel on the QTc Interval in Cancer Patients	abr 2011 (real)
Completado	Fase 2	Menomune®: AAntibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination	abr 2011 (real)
Completado	Fase 1	otamixaban XRP0673Insuficiencia hepatica	abr 2011 (real)
Completado	Fase 3	fexofenadine HCLFexofenadine HCL - Pseudoephedrine HCL Combination Versus Allegra in Patients With Seasonal Allergic Rhinitis	abr 2011 (real)
Completado	Fase 4	ZOLPIDEM · MORFEO CRSleep Satisfaction and Psychomotor Performance of Adults	abr 2011 (real)
Completado	Fase 3	Alemtuzumab · CARE-MS IEsclerosis multiple remitente-recurrente	abr 2011 (real)
Completado	Fase 2	High-Dose Trivalent Inactivated…Gripe	mar 2011 (real)
Completado	Fase 3	DOCETAXELStudy With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF)	mar 2011 (real)
Completado	Fase 2	IniparibStudy of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast Cancer	mar 2011 (real)
Completado	Fase 3	Insulin glargine · PRESCHOOLDiabetes tipo 1	mar 2011 (real)
Completado	no aplica	Agalsidase betaA Long Term Safety and Efficacy Study of Fabrazyme Replacement Therapy in Japanese Patients With Fabry Disease.	mar 2011 (real)
Completado	Fase 1	OmbrabulinA Study to Investigate the Disposition of Radio-labeled AVE8062 Compound Administered as a 30-minute IV Infusion to Patients With Advanced Solid Tumor	mar 2011 (real)
Completado	Fase 3	Lixisenatide · GETGOAL-MDiabetes tipo 2	mar 2011 (real)
Completado	Fase 2	SSR125543 · AGATEA Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder	mar 2011 (real)
Completado	Fase 3	LixisenatideDiabetes tipo 2	mar 2011 (real)
Completado	Fase 2	Purified Vero Rabies VaccineStudy of Purified Vero Rabies Vaccine Serum Free Compared With Reference Purified Vero Rabies Vaccine in Healthy Adults	feb 2011 (real)
Completado	Fase 3	VELOURAflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen	feb 2011 (real)
Completado	Fase 1	AVE8062Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel in Patients With Advanced Solid Tumors	feb 2011 (real)
Completado	Fase 1	Teriflunomide HMR1726Insuficiencia renal	feb 2011 (real)
Completado	Fase 3	Meningococcal Polysaccharide…A Study of Meningococcal Vaccine, Menactra® in Healthy Subjects in India	feb 2011 (real)
Completado	Fase 1	XL765Cancer de pulmon no microcitico	feb 2011 (real)
Completado	Fase 2	ChimeriVax™-JESafety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age	feb 2011 (real)
Interrumpido	Fase 4	INSULIN GLARGINEDiabetes tipo 2	feb 2011 (real)
Completado	Fase 2	Swine AA Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months	ene 2011 (real)
Completado	Fase 1	Pneumococcal vaccine…Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults	ene 2011 (real)
Completado	Fase 3	Lixisenatide · GETGOAL-F1Diabetes tipo 2	ene 2011 (real)
Completado	Fase 3	Lixisenatide · GETGOAL-MONODiabetes tipo 2	ene 2011 (real)
Completado	no aplica	Post Authorization Safety Study of the Pandemic A/H1N1 Influenza Vaccines in Children and Adults	ene 2011 (real)
Completado	Fase 3	Aflibercept · VITALA Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer	ene 2011 (real)
Completado	Fase 3	gemcitabineCancer de mama	ene 2011 (real)
Completado	Fase 1/2	ATN-103Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis	ene 2011 (real)
Completado	Fase 1	SAR153191-P3 drug productArtritis reumatoide	dic 2010 (real)
Completado	Fase 2	Monovalent Subvirion AA Study of Different Formulations of an Adjuvanted A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly	dic 2010 (real)
Completado	Fase 3	LACTIC ACIDDermacyd in Odor Reducing.	dic 2010 (real)
Completado	Fase 3	DocetaxelAdjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy	dic 2010 (real)
Completado	no aplica	TALISMAN SRetrospective Safety Survey In Patients Included In NV1FGF Clinical Trials	dic 2010 (real)
Completado	Fase 4	GLIMEPIRIDE + METFORMIN · AMIT KZDiabetes tipo 2	dic 2010 (real)
Completado	Fase 3	Dermacid SilverComparative Safety and Efficacy Evaluation Between Dermacyd Silver and Glycerine Vegetal Soap Granado Traditional	nov 2010 (real)
Completado	Fase 1	plerixaforStudy of AMD3100 (Plerixafor) and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma	nov 2010 (real)
Completado	Fase 2	OxaliplatinStudy of Neoadjuvant Chemotherapeutic Treatment (XELOX) Followed by Chemoradiotherapy (XELOX/RT) and Surgery Versus Chemoradiotherapy Followed by Surgery and Chemotherapy in Patients With High Risk Rectal Cancer	nov 2010 (real)
Completado	Fase 2	ZD6474Cancer de prostata	nov 2010 (real)
Completado	no aplica	Docetaxel · OCSTUDDocetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer	nov 2010 (real)
Completado	Fase 2	LixisenatideDiabetes tipo 2	nov 2010 (real)
Interrumpido	Fase 2	AVE1642Cancer de mama	nov 2010 (real)
Completado	Fase 3	JE-CV VaccineStudy of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV	oct 2010 (real)
Completado	Fase 3	Idrabiotaparinux sodium · CASSIOPEAClinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach	oct 2010 (real)
Completado	Fase 4	Triamcinolone acetonide aqueousNasacort AQ Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Children With Allergic Rhinitis	oct 2010 (real)
Interrumpido	Fase 3	Idrabiotaparinux sodium · BOREALIS-AFEvaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation	oct 2010 (real)
Completado	Fase 4	GLIMEPIRIDE · SUMERDiabetes tipo 2	oct 2010 (real)
Completado	Fase 4	Insulin glargineDiabetes tipo 2	oct 2010 (real)
Completado	Fase 4	Insulin glargine · LANTITDiabetes tipo 2	oct 2010 (real)
Interrumpido	no aplica	PORTREATObservational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients	oct 2010 (real)
Completado	Fase 4	DTacP-IPV combined vaccineImmunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of Age	sep 2010 (real)
Completado	Fase 2	Swine AA Study of the Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy Adults	sep 2010 (real)
Completado	Fase 2	Swine AA Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years	sep 2010 (real)
Completado	Fase 4	GLIMEPIRIDE · GREATDiabetes tipo 2	sep 2010 (real)
Interrumpido	Fase 1/2	Vandetanib · ZACFASTCancer de ovario	sep 2010 (real)
Completado	Fase 1	Pneumococcal Vaccine…Study of Two Investigational Pneumococcal Vaccines in Healthy Adults	sep 2010 (real)
Completado	Fase 3	Ainfluenza · influenza pandémica · virus de influenza A, subtipo H1N1	ago 2010 (real)
Interrumpido	Fase 1	ZD6474Cancer de pulmon no microcitico	ago 2010 (real)
Completado	Fase 3	clopidogrel · CLEANSafety Evaluation of Clopidogrel Sulfate in Patients With Stable Angina/Old Myocardial Infarction to Whom Percutaneous Coronary Intervention is Being Planned	ago 2010 (real)
Completado	Fase 3	irbesartan · I-COMBINEHipertension	ago 2010 (real)
Completado	Fase 2	larotaxel · SATINCancer de mama	ago 2010 (real)
Completado	Fase 3	Semuloparin Sodium · SAVE-ABDOEvaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery	ago 2010 (real)
Interrumpido	Fase 4	INSULIN GLARGINE · RELIANCEDiabetes tipo 2	ago 2010 (real)
Completado	Fase 2/3	DocetaxelCancer de cabeza y cuello	jul 2010 (real)
Completado	Fase 3	Clopidogrel · CLARINET LTLong Term Safety of Clopidogrel in Neonates/Infants With Systemic to Pulmonary Artery Shunt Palliation	jul 2010 (real)
Completado	Fase 4	ZOLPIDEM SL800750Efficacy and Safety Assessment of ZOlpidem (Stilnox CR) in Patients With Chronic insomNIA	jul 2010 (real)
Completado	Fase 3	Teriflunomide · TEMSOEsclerosis multiple	jul 2010 (real)
Completado	no aplica	InoProOsteoporosis · Cancer de prostata	jul 2010 (real)
Completado	Fase 4	INSULIN GLULISINE · PORTAL 1Diabetes tipo 1	jul 2010 (real)
Completado	Fase 3	Influenza virus vaccineGripe	jul 2010 (real)
Completado	no aplica	RECOVERYCanadian Outpatient VTE Management Registry	jun 2010 (real)
Completado	Fase 4	Coarsucam · SMART-CURECohort Study in Uganda Comparing Artesunate + Amiodaquine (Coarsucam) Versus Artemether + Lumenfantrine (Coartem) in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks	jun 2010 (real)
Completado	Fase 3	Lixisenatide · GETGOAL-L-ASIADiabetes tipo 2	jun 2010 (real)
Completado	Fase 3	FluCAM [Fludara + Campath]Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients	jun 2010 (real)
Completado	Fase 2	Influenza Virus Vaccine USP…Gripe	may 2010 (real)
Completado	Fase 3	FDC KETOPROFEN+OMEPRAZOLEDolor	may 2010 (real)
Completado	Fase 1/2	clofarabineA Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.	may 2010 (real)
Completado	Fase 4	RAMIPRIL HOE498 · HOPETipsEnfermedad coronaria	abr 2010 (real)
Interrumpido	Fase 2	ALVACMelanoma · Cancer	abr 2010 (real)
Completado	Fase 2	Docetaxel + OxaliplatinDocetaxel and Oxaliplatin in Gastric Cancer	abr 2010 (real)
Interrumpido	Fase 2	vandetanib · ZENITHCancer de prostata	abr 2010 (real)
Completado	Fase 3	somatropinMAXOMAT ® in the Treatment of Severe Early Onset Intrauterine Growth Retardation on Pre-pubertal Children	abr 2010 (real)
Completado	Fase 2	TeriflunomideEsclerosis multiple	abr 2010 (real)
Interrumpido	Fase 3	LevofloxacinLEVOS - Levofloxacin and Rifampicin Therapy in the Treatment of OsteoArticular Prothethic Infection	abr 2010 (real)
Completado	Fase 3	KETOPROFENDolor	abr 2010 (real)
Completado	Fase 2	ASafety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children	mar 2010 (real)
Completado	Fase 3	Oxaliplatin + 5-Fluorouracil · EACHOxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients	mar 2010 (real)
Completado	Fase 2	NerispirdineEsclerosis multiple	mar 2010 (real)
Completado	Fase 2	DocetaxelTaxotere + Cisplatin in Nasopharyngeal Carcinoma	mar 2010 (real)
Completado	Fase 2	Monovalent Subvirion AA Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years	mar 2010 (real)
Completado	Fase 3	MetforminDiabetes tipo 2	mar 2010 (real)
Completado	Fase 2	Monovalent Subvirion AA Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly	mar 2010 (real)
Completado	Fase 2	CYD Dengue Vaccine Serotypes 1Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years	feb 2010 (real)
Interrumpido	no aplica	Elitek (Rasburicase) Immuno-Monitoring Study	feb 2010 (real)
Completado	Fase 3	Clopidogrel · CLARINETEfficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To Pulmonary Artery Shunt Palliation	feb 2010 (real)
Completado	Fase 2	SSR411298 · FIDELIOTrastorno depresivo mayor	feb 2010 (real)
Completado	Fase 1	aflibercept · QUTIECancer	feb 2010 (real)
Completado	Fase 3	Adacel®A Study to Assess the Safety of Adacel® Vaccine	feb 2010 (real)
Completado	Fase 2	VandetanibCancer de pulmon no microcitico	ene 2010 (real)
Completado	Fase 2	OxaliplatinPhase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma	ene 2010 (real)
Interrumpido	Fase 2	VinorelbineMesotelioma	ene 2010 (real)
Completado	Fase 4	Irbesartan · COSIMA2Hipertension	ene 2010 (real)
Completado	Fase 2	IRBESARTAN · I-COMBOHipertension	ene 2010 (real)
Completado	Fase 4	amisulpride and risperidone · AMIMINDEsquizofrenia	ene 2010 (real)
Completado	Fase 4	Inactivated Hep A vaccineImmunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine	dic 2009 (real)
Completado	Fase 1	Eplivanserin · PKiDsSingle Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With Insomnia	dic 2009 (real)
Completado	Fase 2	G-CSF plus plerixaforAMD3100 (Plerixafor) With G-CSF in Poor Mobilizing Adult Patients Who Previously Failed Hematopoietic Stem Cell (HSC) Collection/Attempts	dic 2009 (real)
Completado	Fase 2	2009-2010 Trivalent Influenza…Gripe	dic 2009 (real)
Completado	Fase 3	REPEVAXVoluntarios sanos	dic 2009 (real)
Completado	Fase 3	HBVaxPRO® 5 µgHepatitis B	dic 2009 (real)
Completado	Fase 4	alglucosidase alfaHigh Dose or High Dose Frequency Study of Alglucosidase Alfa	dic 2009 (real)
Completado	Fase 4	GlimepirideDiabetes tipo 2	dic 2009 (real)
Completado	Fase 2	ASafety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children	dic 2009 (real)
Completado	Fase 2	gemcitabineCancer de mama	nov 2009 (real)
Interrumpido	Fase 3	Xaliproden · XENONRole of Xaliproden on Recovery Rate From Severe Neuropathy in Patients Who Have Completed Adjuvant Chemotherapy With Oxaliplatin Based Regimens	nov 2009 (real)
Interrumpido	Fase 3	Insulin Glargine · INTENSIVEEffect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction	nov 2009 (real)
Completado	Fase 1	ATN-103Voluntarios sanos	nov 2009 (real)
Completado	Fase 1	ClopidogrelVoluntarios sanos	nov 2009 (real)
Completado	Fase 1	ZD6474Cancer de cabeza y cuello	nov 2009 (real)
Completado	Fase 2	Inactivated types 1Poliomielitis	oct 2009 (real)
Completado	Fase 4	Live Attenuated Varicella Virus…Safety of a Second Dose of Biken's Varicella Vaccine	oct 2009 (real)
Completado	Fase 2	TeriflunomideEsclerosis multiple	oct 2009 (real)
Completado	Fase 3	XaliprodenEvaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.	oct 2009 (real)
Completado	Fase 3	leflunomide · LEADERLeflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid Arthritis	oct 2009 (real)
Completado	Fase 2/3	afliberceptStudy of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites	oct 2009 (real)
Completado	Fase 2	Docetaxel + CDDPDocetaxel in Non Small Cell Lung Cancer (NSCLC)	oct 2009 (real)
Completado	Fase 3	Enoxaparin sodium · SAVE-HIP2Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery	oct 2009 (real)
Interrumpido	Fase 3	Aflibercept · VANILLAAflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer	oct 2009 (real)
Completado	Fase 4	TetanusImmune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose	sep 2009 (real)
Interrumpido	Fase 3	Sevelamer carbonate · ASPIREA Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis	sep 2009 (real)
Completado	Fase 3	cabazitaxel · TROPICXRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer	sep 2009 (real)
Completado	Fase 3	Clopidogrel · CURRENT/OASIS7Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS	sep 2009 (real)
Completado	Fase 1	Monovalent subvirion H5N1…Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine	sep 2009 (real)
Completado	Fase 4	Ramipril + FelodipineHipertension	sep 2009 (real)
Completado	Fase 2	Genz-644470 · LEAPRandomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis	ago 2009 (real)
Completado	Fase 1	Lixisenatide · RESTOREDiabetes tipo 2	ago 2009 (real)
Completado	Fase 3	Irbesartan · ACTIVE IAtrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)	ago 2009 (real)
Completado	Fase 3	ZD6474cancer de tiroides	jul 2009 (real)
Completado	Fase 3	LACTIC ACIDDermacyd Silver Frutal (Lactic Acid) - Photo Evaluation.	jul 2009 (real)
Completado	Fase 3	LACTIC ACIDDermacyd PH_DESILSTY_FL (Lactic Acid) - Acceptability - Stay on Floral.	jul 2009 (real)
Completado	Fase 3	Larotaxel · PAPRIKALarotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen	jul 2009 (real)
Completado	Fase 4	Irbesartan · ACTUALHipertension	jul 2009 (real)
Interrumpido	Fase 3	PROSTATACombination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer	jul 2009 (real)
Completado	Sin fase asignada	Sepraspray · C-MUSTManageability and Safety Assessment of Sepraspray in Abdominal Surgery.	jul 2009 (real)
Completado	Fase 3	LACTIC ACIDDermacyd Silver Frutal (Lactic Acid) - Compatibility.	jul 2009 (real)
Completado	Fase 3	LACTIC ACIDDermacyd Silver Floral (Lactic Acid) - Compatibility.	jul 2009 (real)
Completado	Fase 3	LACTIC ACIDDermacyd Silver Floral (Lactic Acid) - Compatibility - Stay on Floral	jul 2009 (real)
Completado	Fase 3	LACTIC ACIDDermacyd Silver Floral (Lactic Acid) - Photo Evaluation	jul 2009 (real)
Completado	Fase 3	LACTIC ACIDDermacyd PH_DESILSTY_FR (Lactic Acid) - Photo Evaluation - Stay on Frutal	jul 2009 (real)
Completado	Fase 3	LACTIC ACIDDermacyd Silver Floral (Lactic Acid) - Acceptability.	jul 2009 (real)
Completado	Fase 3	LACTIC ACIDDermacyd PH_DESILSTY_FR (Lactic Acid) - Acceptability - Stay on Frutal	jul 2009 (real)
Completado	Fase 1	clopidogrelVoluntarios sanos	jun 2009 (real)
Completado	Fase 2	G-CSF plus plerixaforThe Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD)	jun 2009 (real)
Completado	Fase 4	insulin glargine · COBIN 2Diabetes tipo 2	jun 2009 (real)
Interrumpido	Fase 2	Sargramostim · PREMIERComparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-cell Lymphoma, a Form of Non-Hodgkin's Lymphoma	jun 2009 (real)
Interrumpido	Fase 3	25 mgHipercolesterolemia	jun 2009 (real)
Completado	Fase 2	Polysaccharide Diphtheria…Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®	jun 2009 (real)
Completado	Fase 1	VandetanibCancer de pancreas	jun 2009 (real)
Interrumpido	Fase 2	SAR97276AStudy of SAR97276A in the Treatment of Uncomplicated and Severe Malaria in Adults and Children.	jun 2009 (real)
Completado	Fase 4	Insulin glulisine · PUMPDiabetes tipo 1	jun 2009 (real)
Completado	Fase 2	ataciguat · SERENEATIDolor	jun 2009 (real)
Completado	Fase 2	Influenza virus vaccine…Gripe	jun 2009 (real)
Completado	Fase 3	Semuloparin sodium · SAVE-HIP1Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery	jun 2009 (real)
Completado	Fase 2	Influenza virusGripe	jun 2009 (real)
Completado	Fase 2	Influenza Virus Vaccine USP…Influenza Vaccine Revaccination in Ambulatory Elderly Subjects	jun 2009 (real)
Completado	Fase 2	TeriflunomideEsclerosis multiple	jun 2009 (real)
Completado	Fase 3	Eplivanserin · ECLIPSEEfficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties	jun 2009 (real)
Completado	Fase 2	NerispirdineSingle Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple Sclerosis	jun 2009 (real)
Completado	Fase 3	DTaP IPV HB PRP~T vaccineStudy of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants	may 2009 (real)
Interrumpido	Fase 2	Thymoglobulin® · RISERabbit Anti-thymocyte Globulin in the Treatment of Patients With Low to Intermediate-1 Risk Myelodysplastic Syndrome	may 2009 (real)
Completado	Fase 3	DTaP-IPV-Hep B-PRP~T vaccineStudy of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™	may 2009 (real)
Completado	Fase 3	Influenza Virus Vaccine USP…Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults	may 2009 (real)
Completado	Fase 1	clopidogrelVoluntarios sanos	may 2009 (real)
Completado	Fase 1	GC1008 Human Anti Transforming…Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma	may 2009 (real)
Completado	Fase 2	Menactra®: Meningococcal…Dose Comparison Study of Menactra® in US Children	may 2009 (real)
Completado	Fase 1	ClopidogrelVoluntarios sanos	may 2009 (real)
Interrumpido	Fase 3	Rimonabant · AUDITORAtherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant	abr 2009 (real)
Interrumpido	Fase 3	Rimonabant · CRESCENDOEnfermedad cardiovascular	abr 2009 (real)
Interrumpido	Fase 3	AVE5530Hipercolesterolemia	abr 2009 (real)
Interrumpido	no aplica	AlemtuzumabLeucemia linfocitica cronica	abr 2009 (real)
Completado	Fase 3	TdcP-IPV vaccineImmunogenicity and Safety of Adacel Polio Vaccine	abr 2009 (real)
Interrumpido	Fase 2	AVE0657Evaluation of the Effect of AVE0657 in Cheynes-Stokes Breathing Syndrome Patients	mar 2009 (real)
Completado	Fase 3	clopidogrelAtrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)	mar 2009 (real)
Interrumpido	Fase 3	Rimonabant · RAPSODIRimonabant In Prediabetic Subjects To Delay Onset Of Type 2 Diabetes	mar 2009 (real)
Interrumpido	Fase 4	Insulin Glargine · MalbecDiabetes tipo 2	mar 2009 (real)
Completado	Fase 2	docetaxelDocetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents	mar 2009 (real)
Interrumpido	Fase 3	Semuloparin sodium · SAVE-VEMEDEvaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility	mar 2009 (real)
Completado	Fase 4	LACTIC ACIDDermacyd Infantile - Acceptability.	mar 2009 (real)
Completado	Fase 3	Alfuzosin · ALFACHINAlfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder Dysfunction	mar 2009 (real)
Completado	no aplica	Menactra®Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine	mar 2009 (real)
Completado	Fase 4	irbesartanHipertension	mar 2009 (real)
Completado	Fase 4	LACTIC ACIDDermacyd Infantile (Lactic Acid)- Compatibility.	mar 2009 (real)
Completado	Fase 1/2	larotaxelCancer de mama	mar 2009 (real)
Completado	Fase 3	saredutant · COMPASSAn Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder	feb 2009 (real)
Completado	Fase 2	SSR180575Dose-effect of SSR180575 in Diabetic Neuropathy	feb 2009 (real)
Interrumpido	Fase 3	Rimonabant · PRADOObesidad	feb 2009 (real)
Completado	Fase 4	Coarsucam®Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks	feb 2009 (real)
Completado	Fase 2	InactivatedStudy of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines	feb 2009 (real)
Completado	Fase 2	DoxercalciferolA Study to Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe Psoriasis	feb 2009 (real)
Completado	Fase 2	Hybrid 5 component DTaPStudy of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®	feb 2009 (real)
Completado	Fase 2	docetaxel and cisplatin…Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC)	feb 2009 (real)
Completado	Fase 2	Meningococcal polysaccharide…Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26	feb 2009 (real)
Interrumpido	Fase 3	Rimonabant · SYMPHONYJapanese Study With Rimonabant in Obese Type 2 Diabetic Patients With Oral Anti-diabetic Drug	feb 2009 (real)
Completado	Fase 2	SSR240600C · BILADYSSR240600C Treatment in Women With Overactive Bladder	feb 2009 (real)
Completado	Fase 3	Rimonabant · REASSUREDiabetes tipo 2	feb 2009 (real)
Interrumpido	Fase 3	Rimonabant · TOCCATADiabetes tipo 2	feb 2009 (real)
Completado	Fase 4	enoxaparinEnoxaparin in Acute Venous Thromboembolic Disease	ene 2009 (real)
Completado	Fase 3	Menactra®: Meningococcal…Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers	ene 2009 (real)
Completado	Fase 2	AVE0657Evaluation of the Effect of AVE0657 on Obstructive Sleep Apnea	ene 2009 (real)
Completado	Fase 1	bsi-201 + topotecanA Study Evaluating BSI-201 in Combination With Chemotherapeutic Regimens in Subjects With Advanced Solid Tumors	ene 2009 (real)
Interrumpido	Fase 3	Rimonabant · RIALTOEvaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors	ene 2009 (real)
Interrumpido	Fase 3	Rimonabant · SOLOJapanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and Exercise	ene 2009 (real)
Completado	Fase 1	Influenza A Vaccine: ACAM FLU-A · FLU-AGripe	ene 2009 (real)
Completado	Fase 3	saredutantTrastorno depresivo mayor	ene 2009 (real)
Completado	Fase 3	Alfuzosin · AlfahydroAlfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic Etiology	ene 2009 (real)
Interrumpido	Fase 3	rimonabant · ETERNALEuropean Trial About Effect of RimoNabant on Abdominal Obese Patients With dysLipidemia	ene 2009 (real)
Completado	Fase 3	Meningococcal Polysaccharide…Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers	ene 2009 (real)
Completado	Fase 4	Influenza Virus Vaccine No…Annual Study for Serum Collection for Immunogenicity and Safety Evaluation in Healthy Children Receiving Fluzone®	ene 2009 (real)
Interrumpido	Fase 3	Volinanserin · RESTComparison of Volinanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties	ene 2009 (real)
Completado	Fase 3	Insulin Glargine · OSIRISDiabetes tipo 2	dic 2008 (real)
Completado	Fase 4	Levothyroxin-NaLISA-study : Levothyroxin in Nodular Goiter	dic 2008 (real)
Completado	Fase 4	LactoserumLactoserum (Dermacyd Femina®) and Prevention of Recurrence of Bacterial Vaginosis	dic 2008 (real)
Completado	Fase 2	ASafety and Immunogenicity of an Intramuscular Pandemic Influenza Vaccine in Adults and the Elderly	dic 2008 (real)
Completado	Fase 3	Satavaptan · CATSCirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)	dic 2008 (real)
Completado	Fase 4	Colesevelam hydrochloride…A Study of the Safety and Efficacy of Patients With Familial Hypercholesterolaemia Taking Colesevelam as add-on Therapy to Their Existing Medication	dic 2008 (real)
Completado	Fase 2	IniparibSingle Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	dic 2008 (real)
Completado	Fase 4	clopidogrelSafety and Efficacy of Clopidogrel for Cerebral Infarction Treatment	dic 2008 (real)
Completado	Sin fase asignada	SepraspraySepraspray™ Laparoscopic Myomectomy Study	dic 2008 (real)
Completado	Fase 3	DiphtheriaImmunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months	dic 2008 (real)
Interrumpido	Fase 3	Satavaptan · SPARe-2Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver	dic 2008 (real)
Interrumpido	Fase 3	RimonabantObesidad	dic 2008 (real)
Completado	Fase 4	Insulin glargine · DOMMEDiabetes tipo 2	dic 2008 (real)
Completado	Fase 2	Enteric coated sevelamer · Sevelamer ECSHipercolesterolemia	dic 2008 (real)
Interrumpido	Fase 3	Satavaptan · AQUARIST1A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia	dic 2008 (real)
Completado	Fase 3	Lactic AcidDermacyd Breeze (Lactic Acid) Pocket BR - Compatibility	nov 2008 (real)
Completado	Fase 3	Lactic AcidDermacyd Breeze (Lactic Acid) Pocket BR - Photo Evaluation	nov 2008 (real)
Retirado antes de empezar	Fase 3	RimonabantDiabetes tipo 2	nov 2008 (real)
Completado	Fase 2	VandetanibPhase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)	nov 2008 (real)
Interrumpido	Fase 4	Insulin GlargineDiabetes tipo 2	nov 2008 (real)
Interrumpido	Fase 3	AVE5530Hipercolesterolemia	nov 2008 (real)
Completado	Fase 3	Dermacyd Breeze Pocket BRDermacyd Breeze Pocket BR (Lactic Acid) - Acceptability	nov 2008 (real)
Interrumpido	Fase 3	Rimonabant · ALLEGRODiabetes tipo 2	nov 2008 (real)
Completado	Fase 4	SplitGripe	nov 2008 (real)
Completado	Fase 2	Oxaliplatin + cisplatin +…Oxaliplatin in Esophagus Cancer (Advanced) 1st Line	oct 2008 (real)
Completado	Fase 3	dronedarone · DIONYSOSEfficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation	oct 2008 (real)
Completado	Fase 4	valproate microgranules · VAPOPEpilepsia	oct 2008 (real)
Completado	Fase 2	GemcitabineGemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma	oct 2008 (real)
Interrumpido	Fase 3	Satavaptan · SPARe-1Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver	oct 2008 (real)
Completado	Fase 3	volinanserin · SAMS12Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus	oct 2008 (real)
Completado	Fase 3	docetaxelCancer de mama	oct 2008 (real)
Completado	Fase 2	larotaxelCancer de mama	oct 2008 (real)
Interrumpido	Fase 1	clofarabineSindromes mielodisplasicos	oct 2008 (real)
Completado	Fase 4	alglucosidase alfaLate-Onset Treatment Study Extension Protocol	oct 2008 (real)
Completado	Fase 4	ADACEL®:TetanusPost-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®	oct 2008 (real)
Completado	Sin fase asignada	AlfuzosinBenign Prostatic Hyperplasia in Taiwan	sep 2008 (real)
Completado	Fase 4	IrbesartanHipertension	sep 2008 (real)
Completado	Fase 3	Dermacyd PH_DETINBACKDermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Photo Avaluation	sep 2008 (real)
Completado	Fase 3	Dermacyd PH_DETINLYNDermacyd PH_DETINLYN (Lactic Acid) Sweet Flower - Photo Evaluation.	sep 2008 (real)
Completado	Fase 3	Dermacyd PH_DETINLYN Tangerine…Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid) - Safety.	sep 2008 (real)
Completado	Fase 3	Lactic AcidDermacyd PH_DETINLYN Tangerine Mix (Lactic Acid) - Photo Evaluation	sep 2008 (real)
Completado	Fase 3	Poliomyelitis Vaccine…Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV	sep 2008 (real)
Completado	Fase 2	docetaxelJapanese Study of the Combined Administration of Docetaxel With Prednisolone for Metastatic Hormone Refractory Prostate Cancer	sep 2008 (real)
Completado	Fase 1	AVE1642Mieloma multiple	sep 2008 (real)
Interrumpido	Fase 2	docetaxelCancer de pulmon no microcitico	sep 2008 (real)
Completado	Fase 3	Dermacyd PH_DETINBACKDermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Compatibility	sep 2008 (real)
Completado	Fase 3	Lactic AcidDermacyd PH_DETINBACK Tangerine Mix (Lactic Acid)- Compatibility	sep 2008 (real)
Completado	Fase 2	Ad2 · WALKSafety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication	sep 2008 (real)
Completado	Fase 2	Inactivated Poliomyelitis…Poliomielitis	sep 2008 (real)
Completado	Fase 3	Lactic AcidDermacyd PH_DETINBACK Tangerine Mix (Lactic Acid) - Photo Evaluation	sep 2008 (real)
Completado	Fase 4	ADACEL®: TetanusA Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older	sep 2008 (real)
Completado	Fase 3	DTaP-HB-PRP~T vaccineImmunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™	sep 2008 (real)
Completado	Fase 3	Dermacyd PH_DETINLYNDermacyd PH_DETINLYN (Lactic Acid) Sweet Flower - Compatibility	sep 2008 (real)
Completado	Fase 3	Dermacyd PH_DETINLYNDermacyd PH_DETINLYN (Lactic Acid) Tangerine Mix - Compatibility	sep 2008 (real)
Completado	Fase 3	VandetanibCancer de pulmon no microcitico	sep 2008 (real)
Completado	Fase 3	Lactic AcidDermacyd PH_DETINBACK Tangerine Mix (Lactic Acid) - Safety.	sep 2008 (real)
Completado	Fase 3	insulin glulisine · VARIABILITEDiabetes tipo 1	sep 2008 (real)
Completado	Fase 3	Vandetanib · ZEALCancer de pulmon no microcitico	sep 2008 (real)
Completado	Fase 1	MeningococcalA Phase I, Randomized, Modified Single-blind, Active-controlled (Infants Only), Four-stage, Step-down, Comparative, Multi-center Study	ago 2008 (real)
Completado	Fase 3	Menactra®: Meningococcal…Immunology and Safety of Menactra® in Children in Saudi Arabia	ago 2008 (real)
Interrumpido	Fase 1	SSR97225Neoplasias	ago 2008 (real)
Completado	Fase 2	Influenza virus vaccineImmunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects	ago 2008 (real)
Completado	Fase 3	Meningococcal Polysaccharide…A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers	ago 2008 (real)
Completado	no aplica	Venous Thromboembolism Taskforce Audit Program	ago 2008 (real)
Interrumpido	Fase 1	AVE9633Dose Escalation Safety and Pharmacokinetic Study of AVE9633 as Single Agent in Relapsed/Refractory CD33-Positive Acute Myeloid Leukemia	ago 2008 (real)
Completado	Fase 4	Purified Verocell Rabies VaccineImmunogenicity and Safety of Verorab™ in Indian Population	ago 2008 (real)
Completado	Fase 3	Cetylpyridinium chloride · Cepacol TeenSafety Dermatological Evaluation: Acceptability With Odontological Follow up - Cepacol Teen.	ago 2008 (real)
Completado	Fase 4	Insulin Glargine · Basal PlusDiabetes tipo 2	ago 2008 (real)
Completado	Fase 4	Lactic acid · LACTAFEMAcceptability of Lactacyd Femina	ago 2008 (real)
Completado	Fase 2	AfliberceptStudy of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma	jul 2008 (real)
Completado	Fase 4	Bacillus clausiiEFESO - EFficacy Enterogermina Small Intestinal Bacterial Overgrowth	jul 2008 (real)
Completado	Fase 3	DAPTACEL®.Safety and Immune Response of Different Pediatric Combination Vaccines.	jul 2008 (real)
Interrumpido	Fase 2	SSR180711CEnfermedad de Alzheimer	jul 2008 (real)
Completado	Fase 3	Rimonabant · VICTORIAVIsceral Fat Reduction Assessed by CT-scan On RImonabAnt	jul 2008 (real)
Completado	Fase 3	DTaP-IPV-HB-PRP~T vaccineStudy of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants	jul 2008 (real)
Interrumpido	Fase 1	GMA161Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)	jul 2008 (real)
Completado	Fase 2	ChimeriVax-WN02 Low DoseSafety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults	jun 2008 (real)
Completado	Fase 2	InactivatedImmunogenicity Study of the Influenza Vaccine in Adults	jun 2008 (real)
Completado	Fase 2	SplitStudy of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects	jun 2008 (real)
Completado	Fase 4	IrbesartanHipertension	jun 2008 (real)
Completado	Fase 4	Insulin glargineDiabetes tipo 2	jun 2008 (real)
Completado	Fase 3	PEDIACEL® and Prevenar®Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers	jun 2008 (real)
Interrumpido	Sin fase asignada	SeprasprayEvaluation of the Safety and Effectiveness of Sepraspray™ in Reducing Post-surgical Adhesions	jun 2008 (real)
Completado	Fase 2	SSR150106 · ACCORD-RAArtritis reumatoide	jun 2008 (real)
Completado	Fase 2	AImmunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults	jun 2008 (real)
Completado	Fase 4	IrbesartanHipertension	jun 2008 (real)
Completado	Fase 4	Insulin glargine · L2T3Diabetes tipo 2	jun 2008 (real)
Completado	Fase 3	FluBlok®Gripe	may 2008 (real)
Completado	Fase 2	clofarabineLeucemia mieloide aguda	may 2008 (real)
Completado	Fase 3	Insulin glulisineDiabetes tipo 2	may 2008 (real)
Completado	Fase 2	Fluzone: Influenza virus vaccineGripe	may 2008 (real)
Completado	Fase 3	DTaP-IPV-HB-PRP~TComparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV	may 2008 (real)
Completado	Fase 4	Insulin Glargine · TARGETDiabetes tipo 2	may 2008 (real)
Completado	Fase 4	Insulin Glulisine · SCALEDiabetes	may 2008 (real)
Completado	Fase 3	Lactic acidDermacyd Femina (Lactic Acid) - Photo Dermatological Evaluation of the Irritation and Sensitivity Potential.	may 2008 (real)
Completado	Fase 3	DiphtheriaImmunogenicity and Safety of Pentaxim in South African Infants	may 2008 (real)
Completado	Fase 3	Lactic acidDermacyd Femina Delicata (Lactic Acid)- Photo Dermatological Evaluation of the Irritation and Sensitivity Potential	may 2008 (real)
Completado	Fase 3	DTaP-IPV combined vaccineImmunogenicity and Safety of Tetraxim Versus Local DTP + IPV	abr 2008 (real)
Completado	Fase 4	Influenza Virus VaccineGripe	abr 2008 (real)
Completado	Fase 4	LevofloxacinMDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary Tuberculosis	abr 2008 (real)
Completado	Fase 2	Alemtuzumab plus Fludarabine · ECO-1Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)	abr 2008 (real)
Completado	Fase 2	PlerixaforEvaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM).	abr 2008 (real)
Completado	Fase 3	DiphteriaImmunogenicity and Safety of Pentaxim™ in an Indian Population	abr 2008 (real)
Completado	Fase 2	Lactic AcidLactacyd Radiance (Lactic Acid) Prophetic Patch Test	abr 2008 (real)
Completado	Fase 3	SaredutantAn Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety Disorder	abr 2008 (real)
Completado	Fase 4	Ramipril-Felodipine · RAFEHELPHipertension	abr 2008 (real)
Completado	Fase 1	Insulin glulisineDiabetes tipo 2	abr 2008 (real)
Completado	Fase 3	Pneumo 23Immunogenicity and Safety of a Booster Dose of Pneumo 23® in 12 to 18 Months-Old Children Primed With Prevnar	mar 2008 (real)
Completado	Fase 4	Insulin Glargine · QoLEvaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine	mar 2008 (real)
Completado	Fase 2	VandetanibA Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer	mar 2008 (real)
Completado	Fase 4	docetaxel and cisplatin · Tax-NazoCancer de cabeza y cuello	mar 2008 (real)
Completado	Fase 3	pristinamycin · PRI-angineEfficacy Study of Pristinamycin Versus Amoxicillin to Treat Tonsillitis Induced by Streptococcus in Children	mar 2008 (real)
Completado	Fase 2/3	AVE7688 · RAVEL-1Hipertension	mar 2008 (real)
Completado	Fase 2	VandetanibCancer colorrectal	mar 2008 (real)
Completado	Fase 2	SSR149415An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder	feb 2008 (real)
Completado	Fase 3	Cetylpyridinium chlorideVoluntarios sanos	feb 2008 (real)
Completado	Fase 2	ZD6474Cancer de tiroides	feb 2008 (real)
Completado	Fase 4	Tetanus-diphtheria-acellular…Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine	feb 2008 (real)
Completado	Fase 3	Lactic acidVoluntarios sanos	feb 2008 (real)
Completado	Fase 3	SR58611A · ALBERIOTrastorno depresivo mayor	feb 2008 (real)
Completado	Fase 3	Dermal Gel ExtraA Study to Compare the Safety and Effectiveness of a Non-FDA Approved Device Dermal Gel Extra (DGE) and an FDA Approved Device for the Correction of Nasolabial Folds (NLFs)	feb 2008 (real)
Completado	Fase 3	Lactic acidVoluntarios sanos	feb 2008 (real)
Completado	Fase 2	InactivatedImmunogenicity of the Inactivated Split-Virion Influenza Vaccine in Renal Transplant Subjects	feb 2008 (real)
Completado	Fase 3	saredutantAn Eight-week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive Disorder	feb 2008 (real)
Completado	Fase 3	Lactic acidSafety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Breeze	feb 2008 (real)
Completado	Fase 3	Eplivanserin · GEMSEfficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia	ene 2008 (real)
Completado	Fase 3	Lactic acidSafety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Delicata Pocket BR	ene 2008 (real)
Completado	Fase 3	Tirapazamine · TRACECarcinoma escamoso de cabeza y cuello	ene 2008 (real)
Completado	Fase 3	Idrabiotaparinux sodium · EQUINOXBioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs	ene 2008 (real)
Completado	Fase 1/2	Menomune®: AExploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years	ene 2008 (real)
Completado	Fase 2	AVE2268Diabetes tipo 2	ene 2008 (real)
Completado	Fase 3	DTaP-IPV-HB-PRP~TSafety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.	ene 2008 (real)
Completado	Fase 3	Lactic acidSafety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower	ene 2008 (real)
Completado	Fase 2	ZD6474Cancer de tiroides	ene 2008 (real)
Completado	Fase 3	Lactic acidVoluntarios sanos	ene 2008 (real)
Completado	Fase 3	Lactic acidSafety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower	ene 2008 (real)
Completado	Fase 4	Alfuzosin · SAMBA-ThailandSexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin	dic 2007 (real)
Completado	Fase 3	epidoxorubicineCancer de mama	dic 2007 (real)
Completado	Fase 3	RasburicaseRasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome	dic 2007 (real)
Completado	Fase 2	G-CSF Plus PlerixaforMieloma multiple · Linfoma no Hodgkin	dic 2007 (real)
Completado	Fase 2	SSR149415An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive Disorder	dic 2007 (real)
Completado	Fase 4	Bacillus clausiiDIAMANTE - Diseases Infectious Analysis Microflora Antibiotic Effect	dic 2007 (real)
Completado	Fase 3	Insulin glulisineDiabetes tipo 1	dic 2007 (real)
Completado	Fase 3	Bacillus Clausii · ENIGMAENterogermina® (Bacillus Clausii) In the manaGeMent of diarrheA in Children	dic 2007 (real)
Completado	Fase 4	depakine chrono · GEVANSGulf Evaluation of VAlproate (Depakine Chrono) in maNia Study	dic 2007 (real)
Completado	Fase 2	OxaliplatinCORE: Capecitabine, Oxaliplatin, Radiotherapy and Excision	nov 2007 (real)
Completado	Fase 1	EnoxaparinEtude (Study) Phase I Enox - UnFractionated Heparin (UFH)	nov 2007 (real)
Completado	Fase 3	xaliprodenEnfermedad de Alzheimer	nov 2007 (real)
Completado	Fase 3	amibegronTrastorno depresivo mayor	nov 2007 (real)
Completado	Fase 3	SaredutantA North-American Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety Disorder	nov 2007 (real)
Completado	Fase 3	DTaP-IPV-HB-PRP~T and…Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants	nov 2007 (real)
Completado	Fase 3	eplivanserin · EPLILONGEfficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year	nov 2007 (real)
Completado	Fase 3	Insulin Glulisine · GINGERDiabetes tipo 2	nov 2007 (real)
Completado	Fase 1	ZD6474Cancer colorrectal	oct 2007 (real)
Completado	Fase 3	DTaP-HB-PRP~T combined vaccineStudy Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants	oct 2007 (real)
Completado	Fase 3	alfuzosinEfficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia	oct 2007 (real)
Completado	Fase 3	afuzosinLong Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH	oct 2007 (real)
Completado	Fase 3	xaliprodenEnfermedad de Alzheimer	oct 2007 (real)
Completado	Fase 4	docetaxelDocetaxel in the Treatment of Hormone Refractory Prostate Cancer	oct 2007 (real)
Completado	Fase 4	HectorolStudy of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism	oct 2007 (real)
Completado	Fase 2	InactivatedGripe	sep 2007 (real)
Completado	Fase 3	SSR591813LEfficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN)	sep 2007 (real)
Completado	Fase 4	DiphtheriaImmunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand	sep 2007 (real)
Completado	Fase 3	DT5aP-IPV-Hib 5-component…Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Prevenar®	sep 2007 (real)
Completado	Fase 3	SR121463B · SIADHEfficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion	sep 2007 (real)
Interrumpido	Fase 3	SR58611A · VEGAPrevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety Disorder	sep 2007 (real)
Completado	Fase 2	Docetaxel + carboplatin +…Docetaxel in Non Small Cell Lung Cancer (NSCLC)	sep 2007 (real)
Completado	Fase 4	Influenza Virus VaccineGripe	sep 2007 (real)
Completado	Fase 3	alglucosidase alfaA Placebo-Controlled Study of Safety and Effectiveness of Myozyme (Alglucosidase Alfa) in Patients With Late-Onset Pompe Disease	sep 2007 (real)
Completado	Fase 2	Inactivated influenza vaccineA Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine	ago 2007 (real)
Completado	Fase 2	NAPATrastorno depresivo mayor	ago 2007 (real)
Completado	Fase 3	SR121463B · SIADH SafetySafety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion	ago 2007 (real)
Completado	Fase 1	Pneumococcal VaccineStudy of an Investigational Pneumococcal Vaccine in Healthy Adult Volunteers	ago 2007 (real)
Interrumpido	Fase 3	SR58611A · GEMINIAn Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Generalized Anxiety Disorder	ago 2007 (real)
Completado	Fase 2	Oxaliplatin · FOLFOX4Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function	ago 2007 (real)
Completado	Fase 2	Chimeric dengue serotypeStudy of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects	ago 2007 (real)
Completado	Fase 4	TeicoplaninComparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients	ago 2007 (real)
Completado	Fase 3	eplivanserin · EPOCHEfficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia	ago 2007 (real)
Completado	Fase 1	plerixaforInsuficiencia renal	ago 2007 (real)
Completado	Fase 3	DTaP-IPV-HB-PRP~T vaccineImmunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule	jul 2007 (real)
Completado	Fase 3	Saredutant succinateAn Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression	jul 2007 (real)
Completado	Fase 2	Fludarabine PhosphateEfficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHL	jul 2007 (real)
Completado	Fase 3	amibegronLong Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder	jul 2007 (real)
Completado	Fase 3	High-Dose InactivatedImmunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly	jul 2007 (real)
Completado	Fase 2	ZactimaE3-Hormone Refractory Prostrate Cancer Taxotere Combination	jul 2007 (real)
Completado	Fase 2	HOE140 IcatibantEfficacy and Safety Study of Intra-articular Multiple Doses of Icatibant in Patients With Painful Knee Osteoarthritis	jul 2007 (real)
Completado	Fase 3	SR121463BDILIPO (DILutIonal HyPOnatremia)	jul 2007 (real)
Interrumpido	Fase 4	Insuline glargineDiabetes mellitus tipo 2	jun 2007 (real)
Completado	Fase 4	Influenza Virus VaccineGripe	jun 2007 (real)
Completado	Fase 2	Semuloparin sodium · TREKPrevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery	jun 2007 (real)
Completado	Fase 4	Hectorol®A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis	jun 2007 (real)
Completado	Fase 2	VandetanibCancer de mama avanzado	jun 2007 (real)
Completado	Fase 3	dianicline · EURODIANEfficacy and Safety of Dianicline Versus Placebo as an Aid to Smoking Cessation	jun 2007 (real)
Completado	Fase 4	zolpidem tartrateAmbien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With Lexapro	jun 2007 (real)
Completado	Fase 2	SplitStudy of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly Subjects	jun 2007 (real)
Completado	Fase 4	ArtesunateACT MALI: Treatment of Malaria Based on Combination Therapies	jun 2007 (real)
Completado	Fase 3	SaredutantA Study Evaluating the Safety and Tolerability of Abrupt Discontinuation of Saredutant in Patients With Depression	jun 2007 (real)
Completado	Fase 3	DT5aP-IPV-Hib 5-component…Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants	may 2007 (real)
Completado	Fase 4	laronidaseA Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients	may 2007 (real)
Completado	Fase 2	Hexadecasaccharide · SHINEHexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction	may 2007 (real)
Completado	Fase 3	LevofloxacinStudy to Demonstrate the Clinical Efficacy of Levofloxacin in the Treatment of Pneumonia	may 2007 (real)
Interrumpido	Fase 2	plerixaforMieloma multiple	may 2007 (real)
Interrumpido	Fase 2	SargramostimEnfermedad de Crohn	may 2007 (real)
Interrumpido	Fase 4	Oral IronAnemia	abr 2007 (real)
Completado	Fase 4	EnoxaparineHENOX: Enoxaparine in Hemodialysis	abr 2007 (real)
Completado	Fase 3	DTaP-IPVImmunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants	abr 2007 (real)
Completado	Fase 2	AlfuzosinAlfuzosin for Treating Acute Urinary Retention	abr 2007 (real)
Completado	Fase 4	Insulin glargineDiabetes tipo 2	abr 2007 (real)
Interrumpido	Fase 3	triamcinolone acetonide · RhiCNANIEfficacy and Safety Study of Nasacort in Chronic Non Allergic and Non Infectious Rhinitis in Adults	abr 2007 (real)
Completado	Fase 2	SR57667BEnfermedad de Parkinson	mar 2007 (real)
Completado	Fase 3	Sevelamer carbonateStudy to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis	mar 2007 (real)
Completado	Fase 3	RisedronateRisedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women	mar 2007 (real)
Completado	Fase 2	Oxaliplatin · PROCTFULPreoperative Radiotherapy/ Oxaliplatin/ Capecitabine Treatment For Unresectable Locally-advanced Rectal Cancer	mar 2007 (real)
Completado	Fase 3	MyozymeSafety and Effectiveness Study of rhGAA in Patients With Advanced Late-Onset Pompe Disease Receiving Respiratory Support	mar 2007 (real)
Completado	Fase 3	enoxaparinJapanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture Surgery	mar 2007 (real)
Completado	Fase 4	T dap + Meningococcal…Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine	mar 2007 (real)
Completado	Fase 3	IrbesartanARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation	mar 2007 (real)
Completado	Fase 2	Polysaccharide Diphtheria…Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®	mar 2007 (real)
Completado	Fase 4	IrbesartanHipertensión	feb 2007 (real)
Interrumpido	Fase 2	docetaxel and cisplatinSafety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients	feb 2007 (real)
Completado	Fase 3	alfuzosin · ALFACHIPPharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology	feb 2007 (real)
Completado	Fase 2	SSR149744C · ICARIOSDouble Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS	feb 2007 (real)
Completado	Fase 3	SR58611A · LIBRAEfficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder	feb 2007 (real)
Completado	Fase 2	Meningococcal Polysaccharide…Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®	feb 2007 (real)
Completado	Fase 3	CiclesonideAsma	feb 2007 (real)
Completado	Fase 2	G-CSF Plus PlerixaforLinfoma no Hodgkin · Mieloma multiple	feb 2007 (real)
Completado	Fase 2	InactivatedImmunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the Elderly	feb 2007 (real)
Aprobado para comercializar	no aplica	alglucosidase alfaExpanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Infantile-onset Pompe Disease	feb 2007 (real)
Completado	Fase 3	Rimonabant · ADAGIO-lipidsAn International Study of Rimonabant in Dyslipidemia With AtheroGenic Risk In Abdominally Obese Patients	feb 2007 (real)
Interrumpido	Fase 4	TelithromycinTelithromycin in Acute Exacerbation of Chronic Bronchitis	ene 2007 (real)
Completado	Fase 2	ZD6474ZD6474 Phase IIa Dose Finding Multicentre Study	ene 2007 (real)
Completado	Fase 3	Sevelamer carbonateAn Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis	ene 2007 (real)
Completado	Fase 3	DocetaxelGILT Docetaxel - Non-Small Cell Lung Cancer	ene 2007 (real)
Completado	Fase 3	SR58611A · PHOENIXTrastorno depresivo mayor	ene 2007 (real)
Completado	Fase 2	DocetaxelCancer de prostata	ene 2007 (real)
Completado	Fase 3	SR58611A · ORIONTrastorno depresivo mayor	ene 2007 (real)
Interrumpido	Fase 1/2	SargramostimSafety and Efficacy Study in the Treatment of Pediatric Crohn's Disease	dic 2006 (real)
Completado	Fase 3	Saredutant succinateAn Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression	dic 2006 (real)
Interrumpido	Fase 2	SargramostimOpen-label Trial of Leukine in Active Crohn's Disease	dic 2006 (real)
Completado	Fase 1	Artesunate + AmodiaquineBioavailability of the Fixed Combination of Amodiaquine and Artesunate Under Fed & Fasted Conditions	dic 2006 (real)
Completado	Fase 2	Smallpox vaccineEvaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults	dic 2006 (real)
Completado	Fase 3	Saredutant succinateAn Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression	dic 2006 (real)
Completado	Fase 3	Enoxaparin sodiumEnoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)	dic 2006 (real)
Completado	Fase 2	vandetanibCancer de pulmon	dic 2006 (real)
Completado	Fase 3	Insulin glulisineDiabetes Mellitus insulinodependiente	nov 2006 (real)
Completado	no aplica	AlemtuzumabVitalis Study - Observational Study on the Quality of Life in Patients Under Treatment for B-Chronic Lymphocytic Leukemia (B-CLL)	nov 2006 (real)
Completado	Fase 2	OxaliplatinOxaliplatin in Unresectable Hepatocellular Carcinoma	nov 2006 (real)
Completado	Fase 4	Amisulpride · ASAPEsquizofrenia	nov 2006 (real)
Completado	Fase 4	IrbesartanHipertension	nov 2006 (real)
Completado	Fase 4	RasburicaseRasburicase in Tumor Lysis Syndrome	nov 2006 (real)
Interrumpido	Fase 3	SargramostimEfficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease	oct 2006 (real)
Completado	Fase 2	Fludarabine PhosphateLinfoma no Hodgkin	oct 2006 (real)
Completado	Fase 4	COVAXIS™: TetanusPost-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine	oct 2006 (real)
Completado	Fase 2	G-CSF Plus PlerixaforAMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's Disease	oct 2006 (real)
Interrumpido	Fase 3	SargramostimEfficacy Study of Sargramostim in the Retreatment of Patients Who Have Crohn's Disease Who Have Previously Responded to Treatment With Sargramostim	oct 2006 (real)
Completado	Fase 3	AldurazymeStudy of Aldurazyme® Replacement Therapy in Patients With Mucopolysaccharidosis I (MPS I) Disease	oct 2006 (real)
Completado	Fase 4	Valproic acidValproic Acid Sodium Salt in Bipolar Disorder	oct 2006 (real)
Completado	Fase 4	enoxaparin sodiumEXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization	oct 2006 (real)
Interrumpido	Fase 3	TelithromycinTELI TAD - Telithromycin in Tonsillitis in Adolescents and Adults	sep 2006 (real)
Interrumpido	Fase 4	RisedronateOsteoporosis	sep 2006 (real)
Interrumpido	Fase 4	telithromycin · COBRA IIStudy Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 Days	sep 2006 (real)
Interrumpido	Fase 4	Telithromycin · KEYSKEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections	sep 2006 (real)
Completado	Fase 3	larotaxelBreast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer	sep 2006 (real)
Completado	Fase 3	Insulin glulisineOPAL - Insulin Glulisine, Diabetes Mellitus	sep 2006 (real)
Completado	Fase 2	ChimeriVax™-JE vaccineA Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX	sep 2006 (real)
Completado	Fase 3	hylan G-F 20A Study of the Safety and Efficacy of Hylan G-F 20 (Synvisc) in Patients With Symptomatic Osteoarthritis of the Knee	sep 2006 (real)
Completado	Fase 2	oxaliplatinEXIBIT: Oxaliplatin in Biliary Tract Cancer	sep 2006 (real)
Completado	Fase 3	tirapazamineCancer de cabeza y cuello	sep 2006 (real)
Completado	Sin fase asignada	MyozymeExpanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease	ago 2006 (real)
Completado	Fase 2	SR31747A · ODYSSEYEvaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer	ago 2006 (real)
Completado	Fase 1	AMD11070A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus	ago 2006 (real)
Completado	Fase 3	DiphteriaImmunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan	ago 2006 (real)
Interrumpido	Fase 3	TelithromycinTELI TON - Telithromycin in Tonsillitis	ago 2006 (real)
Completado	Fase 3	Granulocyte colony-stimulating…Linfoma no Hodgkin	jul 2006 (real)
Interrumpido	Fase 3	TelithromycinTELI COM - Telithromycin in Children With Otitis Media	jul 2006 (real)
Completado	Fase 2	OxaliplatinOxaliplatin in Gastric Cancer	jul 2006 (real)
Completado	Fase 4	RasburicaseStudy of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy	jul 2006 (real)
Completado	Fase 2	G-CSF and plerixaforLinfoma no Hodgkin · Mieloma multiple	jul 2006 (real)
Completado	Fase 3	ThyrogenA New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.	jul 2006 (real)
Completado	Fase 2	MyozymeA Study of rhGAA in Patients With Late-Onset Pompe Disease	jul 2006 (real)
Completado	Fase 4	Enoxaparin sodiumPREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)	jul 2006 (real)
Interrumpido	Fase 3	telithromycinOtitis media	jun 2006 (real)
Completado	Fase 3	SargramostimEfficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease	jun 2006 (real)
Completado	Fase 3	Rimonabant · SERENADEDiabetes tipo 2	jun 2006 (real)
Completado	Fase 2	clofarabineLeucemia mieloide aguda	jun 2006 (real)
Completado	Fase 1	ZD6474Phase I FOLFOX Combination	jun 2006 (real)
Completado	Fase 3	ChimeriVax™-JEA Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX	jun 2006 (real)
Interrumpido	Fase 1/2	OxaliplatinOxaliplatin in Rectal Cancer	jun 2006 (real)
Completado	Fase 2/3	MyozymeExtension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602	jun 2006 (real)
Completado	Fase 2	G-CSF Plus PlerixaforLinfoma no Hodgkin · Mieloma multiple	jun 2006 (real)
Completado	Fase 1/2	Influenza virus vaccineGripe	jun 2006 (real)
Interrumpido	Fase 1	Vaccine diluent bufferPhase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study, Safety, Tolerability and Immunogenicity	jun 2006 (real)
Completado	Fase 2/3	CELIVARONE · MAIAPlacebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter	may 2006 (real)
Completado	Fase 2	docetaxel and cisplatin · TAX200006Cancer de cabeza y cuello	may 2006 (real)
Completado	Fase 3	Pentacel™: HCPDT-IPVStudy of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™	may 2006 (real)
Completado	Fase 1	ZD6474ZD6474(Vandetanib) + Alimta Combo Study	may 2006 (real)
Completado	Fase 2	InactivatedStudy of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in Adults	may 2006 (real)
Completado	Fase 4	Influenza Vaccine 2004-2005…Gripe	abr 2006 (real)
Completado	Fase 1/2	DocetaxelCancer de cabeza y cuello	abr 2006 (real)
Completado	Fase 2	rimonabantObesidad	abr 2006 (real)
Completado	Fase 2	rasburicaseRasburicase for Hyperuricemia	abr 2006 (real)
Completado	Fase 2	FabrazymeA Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease	abr 2006 (real)
Completado	Fase 2	CELIVARONE · CORYFEEDouble Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttEr	abr 2006 (real)
Completado	Fase 2	SR57667BEnfermedad de Parkinson	abr 2006 (real)
Completado	Fase 3	SR34006Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)	mar 2006 (real)
Completado	Fase 2	Meningococcal Polysaccharide…Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of Age	mar 2006 (real)
Completado	Fase 3	Sevelamer HydrochlorideStudy of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis	mar 2006 (real)
Completado	Fase 2	sevelamer carbonateEnfermedad renal cronica	mar 2006 (real)
Interrumpido	Fase 1/2	CAMPATHLinfoma no Hodgkin	feb 2006 (real)
Completado	Fase 4	Fluzone®: Influenza Virus…Gripe	feb 2006 (real)
Completado	Fase 3	Clopidogrel · CASTLECASTLE (Clopidogrel And Serum Troponin Level Elevation)	feb 2006 (real)
Completado	Fase 2	Live attenuated Japanese…Study of Live Attenuated ChimeriVax™-Japanese Encephalitis Vaccine	feb 2006 (real)
Completado	Fase 3	Inactivated Poliomyelitis…Poliomielitis	feb 2006 (real)
Completado	Fase 4	Insulin glargineDiabetes tipo 2	feb 2006 (real)
Completado	Fase 4	Fluzone®: Influenza virus…Gripe	feb 2006 (real)
Completado	Fase 4	AlfuzosinALF-ONE : ALFuzosin ONcE Daily	feb 2006 (real)
Completado	Fase 3	XRP6976Cancer	feb 2006 (real)
Completado	Fase 1	Vaccine diluent bufferSafety, Tolerability, and Immunogenicity of a Clostridium Difficile Toxoid Vaccine in Healthy Elderly Volunteers	feb 2006 (real)
Completado	Fase 3	CiclesonideAsma	feb 2006 (real)
Completado	Fase 3	Influenza Virus VaccineGripe	ene 2006 (real)
Completado	Fase 1	Clostridium difficile vaccineSafety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers	ene 2006 (real)
Completado	Fase 3	zolpidem-MREfficacy and Safety of Zolpidem-MR Administered Over a Long Term Period as Needed for Insomnia (ZOLONG)	ene 2006 (real)
Completado	Fase 2	TrilostaneTrilostane for Androgen-Independent Prostate Cancer	ene 2006 (real)
Completado	Fase 4	AldurazymeA Dose-optimization Study of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I (MPS I) Disease	ene 2006 (real)
Completado	Fase 3	somatropinePracticability and Acceptability of Stylomax® in Children	dic 2005 (real)
Completado	Fase 2	HP184HP184 in Chronic Spinal Cord Injury Subjects	dic 2005 (real)
Completado	Fase 2	Thymoglobulin [Anti-Thymocyte…A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection	dic 2005 (real)
Completado	Fase 3	SR34006SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis	dic 2005 (real)
Completado	Fase 4	TelithromycinCHOOSE : Telithromycin, Acute Bacterial Sinusitis	dic 2005 (real)
Completado	Fase 2	SR147778Obesidad	nov 2005 (real)
Completado	Fase 2	AVE2635AAsma	nov 2005 (real)
Completado	Fase 2	DTaP-IPV-HB-PRP~TStudy of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants	nov 2005 (real)
Completado	Fase 3	SR34006SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism	oct 2005 (real)
Completado	Fase 2	SargramostimStudy in Patients With Crohn's Disease Who Are Steroid Dependent, Despite Previous Unsuccessful Attempts to Reduce Steroids Due to Worsening of Crohn's Disease	oct 2005 (real)
Completado	Fase 3	SanOrg34006Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)	sep 2005 (real)
Completado	Fase 4	Fludarabine PhosphateA Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia	sep 2005 (real)
Interrumpido	Fase 3	clopidogrelAtrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)	sep 2005 (real)
Completado	Fase 4	agalsidase betaA Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease	sep 2005 (real)
Completado	Fase 2/3	Enoxaparin sodiumSafety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE)	sep 2005 (real)
Completado	Fase 3	rimonabant · STRATUS-WWEfficacy and Safety of Rimonabant as an Aid to Maintenance of Smoking Cessation	sep 2005 (real)
Completado	Fase 2	SL77.0499-10Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia	ago 2005 (real)
Completado	Fase 4	RamiprilHipertension	ago 2005 (real)
Completado	Fase 3	rimonabantEfficacy and Safety of Rimonabant on Weight Loss and Frequency of Binge Episodes in Obese Patients	ago 2005 (real)
Completado	Fase 2	XRP0038 · TALISMAN 211Dose-finding, Safety and Efficacy Study of NV1FGF in Patients With Intermittent Claudication	ago 2005 (real)
Interrumpido	Fase 2	G-CSF plus plerixaforAMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF Alone	jul 2005 (real)
Completado	Fase 4	ThiocolchicosideThiocolchicoside Injection and Capsule in Treatment of Acute Low Back Pain	jul 2005 (real)
Completado	Fase 2	XRP0038 · TALISMAN202Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease.	jul 2005 (real)
Completado	Fase 3	rimonabant · CIRRUSDejar de fumar	jul 2005 (real)
Completado	Fase 4	Tetanus and Diphtheria Toxoids…Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td	jul 2005 (real)
Completado	Fase 4	RamiprilRamipril 10 mg/Day Prevention	jul 2005 (real)
Completado	Fase 3	ciclesonideEffects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma	jun 2005 (real)
Completado	Fase 4	oxaliplatinMASCOT : Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LV	jun 2005 (real)
Interrumpido	Fase 2	DocetaxelDocetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer	jun 2005 (real)
Completado	Fase 4	Diphtheria and Tetanus Toxoids…Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™	jun 2005 (real)
Completado	Fase 2	eplivanserinEfficacy and Safety of SR46349B in Patients With Sleep Disorders in Fibromyalgia	jun 2005 (real)
Completado	Fase 2/3	MyozymeA Study of the Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe Disease	jun 2005 (real)
Completado	Fase 3	telithromycinJapanese Study Evaluating Safety, Efficacy and Acceptability of Telithromycin in Children With Infections	may 2005 (real)
Completado	Fase 2	satavaptan · SPASatavaptan Dose-Ranging Study in the Prevention of Ascites	may 2005 (real)
Completado	Fase 2	FabrazymeA Study of Fabrazyme in Pediatric Patients With Fabry Disease	may 2005 (real)
Completado	Fase 4	Insulin glargineDiabetes tipo 2	may 2005 (real)
Completado	no aplica	A Prospective, Observational Study in Patients With Late-Onset Pompe Disease	may 2005 (real)
Interrumpido	Fase 2	DocetaxelCancer de prostata metastasico	abr 2005 (real)
Interrumpido	Fase 2	DocetaxelCancer de mama	abr 2005 (real)
Completado	Fase 3	risedronateRisedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women	abr 2005 (real)
Completado	Fase 2	XRP0038 · TALISMAN 201Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease	abr 2005 (real)
Completado	Fase 3	rimonabant · REBAObesidad	abr 2005 (real)
Completado	Fase 2	Docetaxel and GemcitabineCancer de pulmon no microcitico	abr 2005 (real)
Completado	Fase 3	AldurazymePhase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients	mar 2005 (real)
Completado	Fase 2	satavaptan · Hypo~CATSatavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites	mar 2005 (real)
Completado	Fase 3	enoxaparinSYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes	feb 2005 (real)
Completado	Fase 2	ClopidogrelALBION "Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis"	feb 2005 (real)
Completado	Fase 3	Insuline GlulisineDiabetes tipo 1	feb 2005 (real)
Completado	Fase 4	Enoxaparin sodiumEnoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)	feb 2005 (real)
Completado	Fase 3	Clopidogrel · CLARITY-TIMI28Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction	ene 2005 (real)
Interrumpido	Fase 2	Rasburicase · GRAAL2Rasburicase for the Treatment/Prevention of Hyperuricemia in Adult Patients With Relapsing Aggressive Non Hodgkin's Lymphoma	ene 2005 (real)
Completado	Fase 4	IRBESARTANHipertension	ene 2005 (real)
Completado	no aplica	Tetanus and diphtheria toxoids…Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age	dic 2004 (real)
Completado	Fase 1	Insulin GlulisineDiabetes tipo 2	dic 2004 (real)
Completado	Fase 3	rimonabant · STRATUS-METADejar de fumar	nov 2004 (real)
Completado	Fase 3	AlfuzosinALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH	oct 2004 (real)
Completado	Fase 3	TelithromycinJapanese Study Evaluating the Effects of Telithromycin in Children With Community-Acquired Pneumonia	oct 2004 (real)
Completado	Fase 3	TelithromycinJapanese Study Evaluating the Effects of Telithromycin in Children With Acute Otitis Media	oct 2004 (real)
Completado	Fase 1	Insulin GlulisineDiabetes	oct 2004 (real)
Completado	Fase 4	Lantus · GALATEEDiabetes tipo 2	sep 2004 (real)
Completado	Fase 4	TelithromycinTelithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD	sep 2004 (real)
Completado	Fase 2	Fludarabine PhosphateLinfoma	ago 2004 (real)
Completado	Fase 3	RiluzoleEnfermedad de Huntington	jul 2004 (real)
Completado	Fase 4	Irbesartan 150mgHipertension	jun 2004 (real)
Completado	Fase 4	RisedronateRisedronate in the Prevention of Osteoporosis in Postmenopausal Women	jun 2004 (real)
Completado	Fase 3	rimonabantObesidad	jun 2004 (real)
Completado	Fase 4	Insulin glargineDiabetes tipo 1	jun 2004 (real)
Completado	Fase 4	zolpidemInsomnia and Daytime Function in Osteoarthritis	jun 2004 (real)
Completado	Fase 3	Rimonabant · RIO-DiabetesObese Patients With Type 2 Diabetes	may 2004 (real)
Completado	Fase 3	RimonabantObese Patients With or Without Comorbidities (RIO-North America)	abr 2004 (real)
Interrumpido	Fase 2	Meningococcal Polysaccharide…Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy Adults	abr 2004 (real)
Completado	Fase 3	TelithromycinAsma	abr 2004 (real)
Completado	no aplica	Retrospective Survey of Safety of Fourth Dose Pentacel® in Children	abr 2004 (real)
Completado	Fase 2	Meningococcal Polysaccharide…Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents	abr 2004 (real)
Completado	Fase 4	Insulin glargine · SAFIRInsulin Analogue With Continuous Glucose Monitoring System (CGMS) Measurement	mar 2004 (real)
Completado	Fase 3	zolpidem-MREvaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary Insomnia	feb 2004 (real)
Completado	Fase 4	FabrazymeA Study of the Safety and Efficacy of Fabrazyme (Agalsidase Beta) as Compared to Placebo in Patients With Advanced Fabry Disease	ene 2004 (real)
Completado	Fase 4	FexofenadineFexofenadine Study On Filipino Children for The Relief of Perennial And Intermittent Allergic Rhinitis	dic 2003 (real)
Completado	Fase 3	FexofenadineAsma	nov 2003 (real)
Completado	Fase 3	Rimonabant · RIO-LipidsObese Patients With Untreated Dyslipidemias	nov 2003 (real)
Completado	Fase 2	anti-thymocyte globulinSindromes mielodisplasicos	nov 2003 (real)
Completado	Fase 3	FexofenadineAsma	oct 2003 (real)
Completado	Fase 3	rimonabant · STRATUS-EUDejar de fumar	oct 2003 (real)
Completado	Fase 1	XRP0038Gene Expression and Tolerability Study of NV1FGF in Patients With Peripheral Artery Occlusive Disease Planned to Undergo Major Amputation	oct 2003 (real)
Completado	Fase 4	Insulin GlargineDiabetes	sep 2003 (real)
Completado	Fase 3	Dronedarone · ADONISAmerican-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm	sep 2003 (real)
Completado	Fase 3	TelithromycinAMS VS MOXI Ketek vs Avelox in AMS	sep 2003 (real)
Completado	Fase 3	Insulin Glargine · LAPTOPDiabetes tipo 2	ago 2003 (real)
Interrumpido	Fase 2	FabrazymeSevere Renal Disease Study in Fabry Patients Treated With Fabrazyme	ago 2003 (real)
Completado	Fase 2	AStudy of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine	ago 2003 (real)
Completado	Fase 3	Dronedarone · EURIDISEURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS)	ago 2003 (real)
Interrumpido	Fase 2	OxaliplatinPatients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer	ago 2003 (real)
Completado	Fase 2	RISEDRONATERisedronate in Postmenopausal Women With Low Bone Density	jun 2003 (real)
Completado	Fase 2/3	docetaxelTaxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma	jun 2003 (real)
Completado	Fase 4	Meningococcal Polysaccharide…Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune®	may 2003 (real)
Completado	Fase 3	OxaliplatinMOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer	abr 2003 (real)
Completado	Fase 2	Thymoglobulin [Anti-thymocyte…An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.	abr 2003 (real)
Completado	Fase 2	Alglucosidase alfaA Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type II	abr 2003 (real)
Interrumpido	Fase 2	ACAM1000Viruela	mar 2003 (real)
Interrumpido	Fase 3	Dronedarone · ANDROMEDAEuropean Trial of Dronedarone in Moderate to Severe Congestive Heart Failure	ene 2003 (real)
Completado	Fase 3	risedronateOsteoporosis	feb 2002 (real)
Completado	Fase 3	insulin glargineDiabetes tipo 2	oct 2001 (real)
Completado	Fase 1	XRP0038Safety and Tolerability of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease	sep 2001 (real)
Interrumpido	Fase 1	CAMPATHNeoplasias hematologicas	sin fecha
Completado	Fase 4	Fexofenadine HClSingle-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Unit	sin fecha
Completado	Fase 4	LeflunomideArtritis reumatoide	sin fecha
Completado	no aplica	DISCO - Influence of a Simple Information Booklet on the Evolution of Acute Low Back Pain (LBP)	sin fecha
Completado	Fase 3	SR57746Ametastasis · neoplasias colorrectales · carcinoma colorrectal	sin fecha
Completado	Fase 4	Risedronate SodiumSatisfaction and Compliance of Risedronate in PMO	sin fecha
Completado	Fase 2	clofarabinePhase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients	sin fecha
Completado	Fase 1	clofarabineClofarabine in Adult Patients With Advanced Solid Tumors	sin fecha
Completado	Fase 3	tolevamer potassium-sodiumA Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea	sin fecha
Interrumpido	Fase 3	GT267-004A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea	sin fecha
Completado	Fase 2	oxaliplatine · GONCancer de pulmon no microcitico	sin fecha
Sin noticias del promotor	Fase 1/2	MART-1 antigenVaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma	sin fecha
Completado	Fase 4	LeflunomideArtritis reumatoide	sin fecha
Completado	Fase 3	insulin glulisineDiabetes tipo 1	sin fecha
Completado	Fase 2	DocetaxelCancer de pulmon no microcitico	sin fecha
Completado	Fase 2	ZD6474Cancer de pulmon no microcitico	sin fecha
Completado	Fase 4	ZolpidemSTILDEP: Zolpidem in Depressive and Dysthimic Patients	sin fecha
Completado	Fase 2	MitoguazoneLinfoma no Hodgkin · Infeccion por VIH	sin fecha
Completado	Fase 4	urate oxidaseFasturtec TLS Treatment / Prophylysis	sin fecha
Completado	Fase 2/3	XRP6976Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer	sin fecha
Retirado antes de empezar	Fase 2	aminopterinCancer de endometrio	sin fecha
Sin noticias del promotor	Fase 3	FOLFOX regimenCancer colorrectal	sin fecha
Completado	Fase 3	ALFUZOSIN · ALF-ACUTEThe Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score	sin fecha
Completado	Fase 4	amisulprideEsquizofrenia	sin fecha
Completado	Fase 3	clopidogrelEfficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment Elevation	sin fecha
Completado	Fase 4	IrbesartanHipertension	sin fecha
Completado	Fase 1	Insulin glulisineDose-Exposure-Response in Type 1 Diabetes Mellitus	sin fecha
Interrumpido	Fase 4	oxaliplatinCancer colorrectal	sin fecha
Completado	Fase 2	ARD6562PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolone	sin fecha
Completado	Fase 1	Colesevelam hydrochloride…Voluntarios sanos	sin fecha
Completado	Fase 4	TelithromycinKetek in CAP / AECB in Ambulatory Adult Patients	sin fecha
Completado	Fase 2	tolevamer potassium-sodiumA Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea	sin fecha
Completado	Fase 4	irbesartan and…Hipertension	sin fecha
Completado	Fase 4	Actonel · ACTIVATEOsteoporosis	sin fecha
Completado	Fase 3	Insulin glargineDiabetes tipo 1	sin fecha
Completado	Fase 3	Insulin glulisine12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.	sin fecha
Completado	Fase 3	Tolevamer potassium-sodiumA Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea	sin fecha
Completado	Fase 2	ZD6474This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.	sin fecha
Completado	Fase 4	LEFLUNOMIDE · OSRAObjective Study in Rheumatoid Arthritis	sin fecha
Completado	Fase 2	ZD6474This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer	sin fecha
Completado	Fase 3	SynviscA Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the Hip	sin fecha
Completado	Fase 2	clofarabinePhase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL)	sin fecha
Completado	Fase 2	OxaliplatinGEMOX: Oxaliplatin in Pancreatic Cancer	sin fecha
Completado	Fase 4	Sevelamer hydrochlorideEnfermedad renal cronica	sin fecha
Completado	Fase 3	IrbesartanHipertension	sin fecha
Completado	Fase 2	DOCETAXELCancer de mama	sin fecha
Completado	Fase 1	apomineSR-45023A in Treating Patients With Locally Advanced or Metastatic Solid Tumors	sin fecha
Completado	Fase 3	GlimepirideEvaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione	sin fecha
Retirado antes de empezar	Fase 2	ILX-295501ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment	sin fecha
Completado	Fase 3	sodium hyaluronateHUPS: Hyalgan Use in Painful Shoulder	sin fecha
Completado	Fase 4	INSULIN GLARGINEDiabetes	sin fecha
Completado	Fase 2	OxaliplatinA Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer	sin fecha
Completado	Fase 4	RiluzoleEsclerosis lateral amiotrofica	sin fecha
Completado	Fase 4	AlfuzosinOnce Daily Given Alfuzosin in the Treatment of BPH	sin fecha
Completado	Sin fase asignada	Seprafilm Bioresorbable MembraneSeprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery	sin fecha
Completado	Fase 4	fexofenadine HClSingle Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight Personnel	sin fecha
Completado	Fase 3	HylastanArtrosis de rodilla	sin fecha
Completado	Fase 2	GT160-246A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea	sin fecha
Completado	Fase 3	insulin glulisineDiabetes tipo 2	sin fecha
Completado	Fase 3	irinotecan hydrochlorideCancer colorrectal	sin fecha
Completado	Fase 3	glimepirideDiabetes tipo 2	sin fecha
Completado	Fase 2	satavaptan · Normo~CATSatavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites	sin fecha
Completado	Fase 2	OxaliplatinCancer de cabeza y cuello	sin fecha
Completado	Fase 4	INSULIN GLARGINEDiabetes	sin fecha
Completado	Fase 3	Insulin Glargine20 Week Bridging Study in Type II DM	sin fecha
Completado	Fase 4	Insulin GlargineDiabetes tipo 2	sin fecha
Completado	Fase 2	clofarabineLeucemia linfoblastica aguda	sin fecha
Completado	Fase 4	FexofenadineFexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal Allergen	sin fecha
Ya no disponible	no aplica	Plerixafor · EAPThis is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant.	sin fecha
Completado	Fase 4	AlfuzosinMulticenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate Hypertrophy	sin fecha
Completado	Fase 4	FexofenadineFexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine	sin fecha
Completado	Fase 3	ClopidogrelCASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease	sin fecha
Interrumpido	Fase 2	DocetaxelCancer de pulmon no microcitico	sin fecha
Completado	Fase 3	insulin glargineDiabetes	sin fecha
Completado	Fase 2	clofarabineLeucemia mieloide aguda	sin fecha
Completado	Fase 2	OxaliplatinPhase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to Cisplatin	sin fecha
Completado	Fase 4	LantusDiabetes	sin fecha
Completado	Fase 4	Risedronate Sodium · ROSPA-CTxA Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis	sin fecha
Completado	no aplica	Screening Protocol to Evaluate Acid Alpha-Glucosidase (GAA) Activity and GAA Gene Mutations in Patients With Late Onset Pompe Disease	sin fecha
Completado	Fase 4	RasburicaseRasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis Syndrome	sin fecha
Completado	Fase 2	satavaptanEfficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion	sin fecha
Completado	Fase 4	LactoserumTopic Compatibility Lactoserum (Dermacyd Delicata - New Fragrance)	sin fecha
Completado	Fase 2	oxaliplatinCancer colorrectal	sin fecha
Completado	Fase 4	Insulin GlargineDiabetes tipo 2	sin fecha
Completado	Fase 3	LevofloxacinLevofloxacin, Chronic Bacterial Prostatitis	sin fecha
Completado	Fase 1	ZactimaCancer de pulmon no microcitico	sin fecha
Completado	Fase 2	ClopidogrelPlatelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)	sin fecha
Completado	Fase 3	lactoserumAcceptability Dermacyd Wipes - Lactoserum - Hygiene	sin fecha
Aprobado para comercializar	no aplica	AMD3100 + G-CSF · CUPAccess Program for Use of AMD3100 to Increase Peripheral Blood Stem Cells for Transplantation in Patients Who Have Failed Standard Therapy Stem Cell Mobilization	sin fecha
Completado	Fase 4	fluorouracil cream 0.5%An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses	sin fecha
Completado	Fase 4	Insulin glargineDiabetes tipo 2	sin fecha
Completado	Fase 4	Fexofenadine HClA Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy Symptoms	sin fecha
Completado	Fase 2	recombinant human acid…Safety and Efficacy of Recombinant Human Acid Alpha-Glucosidase in the Treatment of Classical Infantile Pompe Disease	sin fecha
Completado	Fase 4	HectorolA Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection	sin fecha
Completado	Fase 4	insulin glargineDiabetes tipo 2	sin fecha
Completado	Fase 4	ClopidogrelEffect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial Function	sin fecha
Completado	Fase 4	AmisulprideEsquizofrenia	sin fecha
Completado	Fase 1	apomineSR-45023A in Treating Patients With Advanced Solid Tumors	sin fecha
Completado	Fase 2	Otamixaban · SEPIA-PCIThe SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention	sin fecha
Completado	Fase 4	Valproate sodiumVALID : VAlproate Versus LIthium in Bipolar Disorders	sin fecha
Completado	Fase 4	IRBESARTANHipertension	sin fecha
Completado	Fase 2	ILX651Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel	sin fecha
Completado	Fase 4	zolpidem tartrateResidual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo	sin fecha
Completado	Fase 4	IrbesartanHipertension	sin fecha
Completado	Fase 4	ThiocolchicosideEMINEM: Efficacy of Muscoril In NEck Myofascial Syndromes	sin fecha
Completado	Fase 3	lactoserumTopic Compatibility Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene	sin fecha
Completado	Fase 4	zolpidem tartrateAmbien CR vs. Placebo For Treatment Of Insomnia Associated With Anxiety When Used Concomitantly With Escitalopram (Lexapro)	sin fecha
Completado	Fase 4	Insulin GlulisineDiabetes tipo 1	sin fecha
Completado	Fase 4	risedronate sodiumRisedronate Sodium in Post Menopausal Osteoporosis	sin fecha
Sin noticias del promotor	Fase 1/2	aldesleukinVaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma	sin fecha
Completado	Fase 3	Enoxaparin sodiumTotal Hip Replacement Study With XRP4563 (Enoxaparin Sodium)	sin fecha
Completado	Fase 3	FabrazymeA Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease	sin fecha
Completado	Fase 4	clindamycin 1%Acne vulgar	sin fecha
Completado	Fase 2	Fetal porcine cellsEnfermedad de Parkinson	sin fecha
Completado	Fase 4	Alfuzosin · ALEX-XLAlfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study	sin fecha
Completado	Fase 3	ciclesonideAsma	sin fecha
Retirado antes de empezar	Fase 4	FabrazymeA Study in Patients With Fabry Disease Who Are on Chronic Hemodialysis Therapy for Treatment of End-stage Renal Insufficiency.	sin fecha
Completado	Fase 4	Fexofenadine HCIComparative Study Evaluating the Effects of Fexofenadine HCI 180 mg With Orange Juice Versus Placebo With Orange Juice in a Skin Wheal and Flare Challenge Model.	sin fecha
Completado	Fase 4	CerezymeA Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease.	sin fecha
Completado	Fase 3	AlfuzosinClinical Trial in Males With BPH (Enlarged Prostate)	sin fecha
Completado	Fase 4	insulin glargineDiabetes	sin fecha
Retirado antes de empezar	Fase 1/2	AMD3100Leucemia mieloide aguda · Sindromes mielodisplasicos	sin fecha
Completado	Fase 4	INSULIN GLARGINEDiabetes	sin fecha
Completado	Fase 1	Lantus®Lantus in Prediabetes	sin fecha
Completado	Fase 4	HectorolA Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis	sin fecha
Completado	Fase 3	Irbesartan · PRIMEHipertension	sin fecha
Completado	Fase 2	Sevelamer hydrochlorideEnfermedad renal cronica	sin fecha
Interrumpido	Fase 3	Alfuzosin · ALF-RIKAlfuzosin Versus Placebo in Acute Urinary Retention	sin fecha
Completado	Fase 3	SynviscA Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder Osteoarthritis	sin fecha
Completado	Fase 3	insulin glulisineDiabetes tipo 2	sin fecha
Ya no disponible	no aplica	iniparibCancer de mama	sin fecha
Interrumpido	Fase 4	RisedronateRisedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation	sin fecha
Completado	Fase 3	paracetamol 4.8% paediatric…Paracetamol Oral Paediatric Suspension at 4.8% : Study of Acceptability and Safety.	sin fecha
Completado	Fase 4	Artesunate · ATOLArsucam® (Artesunate + Amiodaquine) Efficacy and TOLerance	sin fecha
Completado	Fase 3	NADGLA Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)	sin fecha
Completado	Fase 4	risedronate sodiumOPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women	sin fecha
Completado	Fase 3	insulin glulisineDiabetes tipo 2	sin fecha
Completado	Fase 1	Modified Release rhTSHVoluntarios sanos	sin fecha
Completado	Fase 3	SynviscArtrosis	sin fecha
Completado	Fase 1	intoplicineChemotherapy in Treating Patients With Advanced or Metastatic Solid Tumors	sin fecha
Interrumpido	Sin fase asignada	Seprapack Sinus DressingEfficacy of Seprapack Sinus Dressing Versus No Dressing in the Prevention of Intranasal Adhesions Following Sinus Surgery	sin fecha
Completado	Fase 4	insulin glargine [rDNA origin]…Diabetes tipo 2	sin fecha
Completado	Fase 4	Insulin GlargineDiabetes	sin fecha
Completado	Fase 3	cisplatinCancer de pulmon	sin fecha
Completado	Fase 4	Risedronate SodiumPOWER Point of Care Effect on Satisfaction of Treatment	sin fecha
Completado	Fase 1/2	Allogeneic DCs and Autologous…Safety/Efficacy of a Vaccine Prepared From Dendritic Cells Combined With Tumor Cells to Treat Advanced Kidney Cancer	sin fecha
Completado	Fase 1/2	DeferitrinIron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia	sin fecha
Completado	Fase 4	GLIMEPIRIDEDiabetes	sin fecha
Completado	Fase 1	Insulin glulisineGlulisine Pre- and Postmeal	sin fecha
Completado	no aplica	RIATHipertension	sin fecha
Completado	Fase 2	DocetaxelTAX + Carboplatin or Cisplatin 1st Line Post-Surgery Ovarian	sin fecha
Completado	Fase 3	insulin glulisineDiabetes tipo 2	sin fecha

Superar una fase no apaga la anterior: es normal ver el mismo fármaco en dos ensayos a la vez, cada uno en la suya, mientras el de antes sigue con los pacientes que ya entraron y no admite nuevos. La fecha de lectura marcada como prevista es una estimación del promotor, no un compromiso: se mueve, y moverse es a veces la noticia. Las marcadas como real ya han ocurrido.

Acciones en circulación

Cuántas acciones existen de esta empresa, según lo que ella misma declara en cada informe. Cada acción nueva reparte el mismo negocio entre más dueños: si la curva sube y tú no compras más, tu parte baja. Una biotecnológica sin ingresos casi solo puede financiarse emitiendo, así que subir no es por sí mismo una mala noticia — lo que se mira es cuánto y cuando. Qué significa cada documento.

De 1.254.019.904 (31 dic 2017) a 1.219.427.096 (31 dic 2025) acciones. El eje empieza en cero.

Posiciones cortas declaradas a FINRA

Qué es vender en corto. Lo que los miembros de FINRA declaran cada quincena sobre esta empresa. FINRA lo publica al septimo día hábil tras cada liquidación y el fichero llega aquí unos días después: lo que ves tiene entre dos y cuatro semanas, según cuando entro y cuánto falta para el siguiente. Aquí se publica el dato; no se interpreta.

Acciones cortas: 9,3
Sobre el capital: 0,8%
Variación: +1.061.388
Días para cubrir: 4,3

El porcentaje es sobre las acciones en circulación, que no es lo mismo que el capital flotante: el flotante descuenta lo que tienen iniciados y accionistas restringidos, así que siempre es menor y el porcentaje sobre el sería mayor. No lo publicamos porque la SEC solo da el flotante en dólares y una vez al año, y pasarlo a acciones pediría el precio de ese día.

Ver las 2 quincenas anteriores

Quincena	Acciones cortas	Sobre el capital	Variación	Días para cubrir
31 ago 2026	8,2 M	0,7%	+920.534	4,0
14 ago 2026	7,3 M	0,6%	-2.879.306	2,6

Fuente: el fichero de FINRA de esa quincena, que es lo que se lee aquí, donde esa quincena figura como SNY.

Qué hacen sus directivos con sus acciones

No hay ninguna compra ni venta a precio de mercado de sus directivos entre lo leído. Puede que no haya habido ninguna, o que sus formularios 4 solo declaren retribución --concesiones, opciones, entregas para pagar impuestos--, que no sale aquí a proposito.

Quién tiene más del 5%

Lo declara el propio accionista ante la SEC al cruzar ese umbral, y después cada vez que su posición cambia de forma significativa. De cada grupo, su última declaración. Solo desde diciembre de 2024: es cuando la SEC hizo obligatorio presentar estas declaraciones en formato estructurado. Las anteriores son documentos de texto libre y no se leen aquí, así que un accionista que declaro antes y no ha vuelto a hacerlo NO sale. ⚠️ Y cada declarante calcula su porcentaje a su manera —unos sobre las acciones en circulación y otros añadiendo los derechos que podrían ejercer—, así que dos cifras de la misma empresa no son estrictamente comparables.

Quién declara	Tipo	Del capital	Acciones	Declarado el
Amundi y 2 más del mismo grupo: AMUNDI · AMUNDI ASSET MANAGEMENT	13G · 12ª enmienda	5,65%	68.651.904	22 jul 2026

Un — en el porcentaje significa que el documento no trae una cifra que se pueda leer —a veces remite a la portada en texto libre—, nunca «cero»; en Acciones, que el declarante no puso el número; y en Quién declara, que en vez de un nombre escribió un párrafo entero del formulario y preferimos no publicarlo antes que publicar eso como si fuera un nombre.

El sector se mira también en conjunto, en las herramientas: el radar de dilución ordena por los trimestres de caja que quedan, el ranking de posiciones cortas por días para cubrir, las operaciones de directivos por fecha, los accionistas de más del 5% por lo que declaran, y el calendario por la fecha que cada promotor estima para su siguiente lectura. Son listas del sector: sale quien tiene ese dato declarado. Piden cuenta.

Documentos presentados ante la SEC83

Se enseñan los 40 más recientes.

Va en color lo que cambia el capital o avisa de un riesgo: las emisiones con precio (424B1, 424B2, 424B4 y 424B5), los 8-K con item 1.02, 1.03, 2.04, 3.01, 3.02 y 4.02, y cualquier documento en el que haya aparecido una frase vigilada, que va citada debajo. Lo demás va en tinta normal. Una cita marcada «por primera vez» es una frase que no estaba en el informe previo del mismo tipo de esa empresa. La etiqueta del formulario lleva a su explicación.

2026

1 oct 20266-KHecho relevante (emisor extranjero)EDGAR
17 sep 20266-KHecho relevante (emisor extranjero)EDGAR
25 ago 2026N-PXN-PXEDGAR
6 ago 20266-KHecho relevante (emisor extranjero)EDGAR
30 jul 20266-KHecho relevante (emisor extranjero)EDGAR
30 jul 20266-KHecho relevante (emisor extranjero)EDGAR
28 jul 202613F-HRCartera trimestral de un gestor institucionalEDGAR
27 jul 20266-KHecho relevante (emisor extranjero)EDGAR
22 jul 2026SC 13G/ACambio en participación significativaEDGAR
17 jul 20266-KHecho relevante (emisor extranjero)EDGAR

Ver los 30 anteriores

2026

7 jul 20266-KHecho relevante (emisor extranjero)EDGAR
30 jun 2026NT 11-KAviso de retraso del informe del plan de empleadosEDGAR
30 jun 202611-KInforme anual del plan de acciones de empleadosEDGAR
30 jun 202611-KInforme anual del plan de acciones de empleadosEDGAR
30 jun 2026NT 11-KAviso de retraso del informe del plan de empleadosEDGAR
24 jun 20266-KHecho relevante (emisor extranjero)EDGAR
22 jun 20266-KHecho relevante (emisor extranjero)EDGAR
12 jun 20266-KHecho relevante (emisor extranjero)EDGAR
8 jun 20266-KHecho relevante (emisor extranjero)EDGAR
28 may 2026SDInforme de divulgación especializadaEDGAR
27 may 20266-KHecho relevante (emisor extranjero)EDGAR
7 may 202613F-HRCartera trimestral de un gestor institucionalEDGAR
5 may 20266-KHecho relevante (emisor extranjero)EDGAR
29 abr 20266-KHecho relevante (emisor extranjero)EDGAR
27 abr 20266-KHecho relevante (emisor extranjero)EDGAR
23 abr 20266-KHecho relevante (emisor extranjero)EDGAR
15 abr 20266-KHecho relevante (emisor extranjero)EDGAR
10 abr 2026SC 13G/ACambio en participación significativaEDGAR
31 mar 20266-KHecho relevante (emisor extranjero)EDGAR
24 mar 20266-KHecho relevante (emisor extranjero)EDGAR
10 mar 20266-KHecho relevante (emisor extranjero)EDGAR
4 mar 20266-KHecho relevante (emisor extranjero)EDGAR
3 mar 20266-KHecho relevante (emisor extranjero)EDGAR
23 feb 20266-KHecho relevante (emisor extranjero)EDGAR
17 feb 2026SC 13G/ACambio en participación significativaEDGAR
17 feb 20266-KHecho relevante (emisor extranjero)EDGAR
17 feb 2026IRANNOTICEIRANNOTICEEDGAR
17 feb 2026S-8Registro de acciones para empleadosEDGAR
17 feb 202620-FInforme anual (emisor extranjero)EDGAR
12 feb 20266-KHecho relevante (emisor extranjero)EDGAR